{"gene":"MMACHC","run_date":"2026-04-28T18:30:28","timeline":{"discoveries":[{"year":2005,"finding":"MMACHC was identified as the gene responsible for cblC-type methylmalonic aciduria and homocystinuria; transduction of wild-type MMACHC into immortalized cblC fibroblast cell lines corrected the cellular phenotype (impaired synthesis of adenosylcobalamin and methylcobalamin), establishing its essential role in intracellular cobalamin processing.","method":"Homozygosity mapping, haplotype analysis, mutation identification in 204 patients, retroviral transduction complementation of cblC fibroblasts","journal":"Nature genetics","confidence":"High","confidence_rationale":"Tier 2 — functional complementation in patient cell lines, replicated across large cohort; foundational discovery paper","pmids":["16311595"],"is_preprint":false},{"year":2009,"finding":"The MMACHC (cblC) protein catalyzes in vitro and in vivo decyanation of cyanocobalamin (CNCbl) and dealkylation of naturally occurring alkylcobalamins (MeCbl, AdoCbl, and straight-chain alkylcobalamins C2–C6); cblC mutant fibroblasts failed to convert propylcobalamin to AdoCbl or MeCbl, confirming MMACHC is responsible for early processing of both CNCbl and alkylcobalamins in mammalian cells.","method":"Radioisotopic (57Co) substrate conversion assays in cultured endothelial cells and patient vs. control skin fibroblasts; in vitro enzymatic assays","journal":"Molecular genetics and metabolism","confidence":"High","confidence_rationale":"Tier 1 — in vitro and cell-based enzymatic assays with patient-derived loss-of-function controls","pmids":["19447654"],"is_preprint":false},{"year":2009,"finding":"Wild-type MMACHC binds both OHCbl and CNCbl with similar micromolar affinity (Kd ~5.7 µM) and binds CNCbl in the 'base-off' configuration; NADPH and FAD are required for reductive decyanation of CNCbl to cob(II)alamin. The G147D mutation abolishes binding of both CNCbl and OHCbl (explaining vitamin unresponsiveness), while R161Q retains OHCbl binding but is impaired in CNCbl binding and decyanation (explaining selective OHCbl responsiveness).","method":"Recombinant protein binding assays, spectroscopic analysis of base-off CNCbl binding, in vitro decyanation assays with NADPH/FAD, patient mutation analysis","journal":"Molecular genetics and metabolism","confidence":"High","confidence_rationale":"Tier 1 — reconstituted in vitro enzymatic and binding assays with mutagenesis","pmids":["19700356"],"is_preprint":false},{"year":2012,"finding":"Crystal structure of human MMACHC bound to adenosyl-Cbl revealed a nitroreductase scaffold that binds AdoCbl in a 'base-off, five-coordinate' configuration. An arginine-rich pocket (including Arg161) is required for glutathione (GSH) binding and dealkylation activity. MMACHC dimerizes via reciprocal exchange of a conserved 'PNRRP' loop that caps the upper axial ligand in trans and is required for proper dealkylation. Mutation of conserved arginines (including disease-associated Arg161Gln) disrupts GSH binding and dealkylation.","method":"X-ray crystallography, solution studies (dimerization triggered by AdoCbl or FMN binding), site-directed mutagenesis, dealkylation activity assays","journal":"Biochemistry","confidence":"High","confidence_rationale":"Tier 1 — crystal structure with functional mutagenesis validation and solution studies; multiple orthogonal methods in single study","pmids":["22642810"],"is_preprint":false},{"year":2010,"finding":"MMACHC protein is thermolabile in its apo form (Tm ~39°C); binding of cobalamins substantially stabilizes the protein (AdoCbl provides the greatest stabilization, ΔTm ~16°C). The late-onset disease mutant R161Q is less thermostable and is less stabilized by cobalamins compared to wild-type, suggesting protein instability as a disease mechanism.","method":"Differential scanning fluorimetry, isothermal denaturation of recombinant wild-type and R161Q MMACHC proteins with various cobalamin ligands","journal":"Molecular genetics and metabolism","confidence":"High","confidence_rationale":"Tier 1 — rigorous in vitro biophysical characterization of purified recombinant wild-type and mutant proteins with multiple ligands","pmids":["20219402"],"is_preprint":false},{"year":2010,"finding":"MMACHC and MMADHC interact directly: MMADHC was confirmed as a binding partner for MMACHC both in vitro (surface plasmon resonance) and in vivo (bacterial two-hybrid). MMACHC binds MeCbl and AdoCbl with higher affinity (Kd ~1.4–1.7 µM) than CNCbl and OHCbl (Kd ~6.4–9.8 µM).","method":"Surface plasmon resonance, bacterial two-hybrid, dynamic light scattering, solution-phase intrinsic fluorescence, phage display mapping of binding sites","journal":"Molecular genetics and metabolism","confidence":"High","confidence_rationale":"Tier 2 — multiple orthogonal biophysical methods confirming protein-protein interaction and cobalamin binding affinities","pmids":["21071249"],"is_preprint":false},{"year":2012,"finding":"Subcellular fractionation and immunofluorescence established that MMACHC is exclusively cytoplasmic, while MMADHC is both mitochondrial and cytoplasmic, consistent with MMACHC functioning in cytoplasmic cobalamin processing and MMADHC acting as a branch point for cofactor delivery to cytoplasm and mitochondria. Retroviral GFP-tagged MMACHC rescued all biochemical defects in cblC fibroblasts.","method":"Immunofluorescence, subcellular fractionation, retroviral complementation of cblC and cblD fibroblasts","journal":"Molecular genetics and metabolism","confidence":"High","confidence_rationale":"Tier 2 — direct localization by two independent methods with functional complementation","pmids":["23270877"],"is_preprint":false},{"year":2012,"finding":"MMADHC does not bind cobalamin but interacts with MMACHC through its structured C-terminal domain; MMACHC self-association is weaker than its interaction with either MMADHC isoform. Phage display predicted four MMACHC-binding sites on MMADHC, two overlapping with MMACHC self-association sites.","method":"Clear-native PAGE, dynamic light scattering, circular dichroism, phage display, surface plasmon resonance","journal":"Molecular genetics and metabolism","confidence":"High","confidence_rationale":"Tier 1–2 — multiple biophysical methods characterizing interaction with mutagenesis-informed mapping","pmids":["22832074"],"is_preprint":false},{"year":2013,"finding":"CblC (MMACHC) and CblD (MMADHC) form a stable complex particularly under conditions that permit dealkylation of alkylcobalamin by CblC or in the presence of the dealkylated product hydroxocobalamin; CblD functions downstream of CblC and controls cofactor partitioning between cytoplasmic MeCbl and mitochondrial AdoCbl pathways. The CblD N-terminal 115 residues are not required for CblC interaction.","method":"Co-immunoprecipitation of complex from fibroblast cell lines, pulldown with CblD variants, limited proteolysis, dealkylation assays","journal":"Biochimie","confidence":"High","confidence_rationale":"Tier 2 — reciprocal co-IP with functional context, confirmed with multiple CblD variants","pmids":["23415655"],"is_preprint":false},{"year":2013,"finding":"Methionine synthase (MS) interacts with MMACHC; this interaction is decreased by cblC disease mutations R161Q and R206W in MMACHC as shown by co-immunoprecipitation and proximity ligation assay. 3D modelling showed MS provides a loop making contacts with MMACHC residues R161 and R206.","method":"Co-immunoprecipitation, proximity ligation assay (DuoLink), 3D modelling and docking, siRNA knockdown of MS in HEK cells","journal":"Human molecular genetics","confidence":"High","confidence_rationale":"Tier 2 — multiple orthogonal methods (co-IP, PLA, computational modeling) across multiple cell lines","pmids":["23825108"],"is_preprint":false},{"year":2015,"finding":"Crystal structure of the MMADHC C-terminal region revealed a modified nitroreductase fold with surprising structural homology to MMACHC despite low sequence conservation. MMACHC processes Cbl prior to interaction with MMADHC; patient mutations on both proteins interfere with complex formation. SAXS revealed a 1:1 MMACHC–MMADHC heterodimer where the interaction region overlaps with the MMACHC–Cbl binding site.","method":"X-ray crystallography (2.2 Å), small angle X-ray scattering (SAXS), mutagenesis of disease-associated residues, interaction mapping","journal":"The Journal of biological chemistry","confidence":"High","confidence_rationale":"Tier 1 — crystal structure plus SAXS plus disease mutation functional validation; multiple orthogonal methods","pmids":["26483544"],"is_preprint":false},{"year":2015,"finding":"Pathogenic missense mutations R161Q (late-onset) and R161G (early-onset) at the same MMACHC residue selectively decrease dealkylation but not decyanation activity, impair glutathione binding, and reduce protein stability. Both mutants exhibit increased futile thiol oxidase cycling (GSH oxidation to GSSG) in the presence of physiological glutathione concentrations, explaining the increased oxidative stress in cblC patients.","method":"In vitro enzymatic assays for dealkylation and decyanation, glutathione binding assays, thiol oxidase activity assays, protein stability measurements with purified recombinant proteins","journal":"The Journal of biological chemistry","confidence":"High","confidence_rationale":"Tier 1 — reconstituted in vitro assays with mutagenesis; mechanistic explanation for genotype-phenotype difference","pmids":["25809485"],"is_preprint":false},{"year":2016,"finding":"MS, MSR, MMACHC, and MMADHC form a multiprotein complex in the cytoplasm for intracellular cobalamin processing; novel interactions of MSR with MMACHC and with MMADHC, and MS with MMADHC were identified. Absence of MS or MMACHC expression disrupts interactions among other complex members.","method":"Co-immunoprecipitation, DuoLink proximity ligation assays in patient fibroblasts with cblG, cblE, and cblC defects, and siRNA-transfected HepG2 cells","journal":"Biochimica et biophysica acta. Molecular basis of disease","confidence":"High","confidence_rationale":"Tier 2 — reciprocal co-IP and proximity ligation assay across multiple genetic backgrounds","pmids":["27771510"],"is_preprint":false},{"year":2017,"finding":"The antivitamin B12 compound F2PhEtyCbl binds human CblC (MMACHC) with high affinity (KD = 130 nM) in the presence of GSH, resists dealkylation by CblC, and stabilizes the ternary CblC–F2PhEtyCbl–GSH complex. The crystal structure of this inactive ternary complex revealed binding interactions between the antivitamin and CblC and the organization of GSH and base-off cobalamin in the active site.","method":"Crystal structure of ternary CblC–antivitamin–GSH complex, KD measurement, enzymatic stability assay","journal":"Angewandte Chemie (International ed. in English)","confidence":"High","confidence_rationale":"Tier 1 — crystal structure of active site complex with biochemical validation","pmids":["28544088"],"is_preprint":false},{"year":2017,"finding":"Novel coordination chemistry of CblC-bound cobalamin supports thiol oxidase activity via a glutathionyl-cobalamin intermediate; deglutathionylation by a second GSH molecule yields GSSG. The R161G and R161Q disease mutations in human CblC unmask latent thiol oxidase activity present in wild-type CblC (C. elegans CblC as model). Crystal structure of C. elegans CblC showed architectural differences at the α- and β-faces of cobalamin that promote or suppress this activity.","method":"In vitro thiol oxidase activity assays, crystal structure of C. elegans CblC, UV-vis and EPR spectroscopy, mutant CblC characterization","journal":"The Journal of biological chemistry","confidence":"High","confidence_rationale":"Tier 1 — crystal structure plus mechanistic enzymatic assays with human disease mutations","pmids":["28442570"],"is_preprint":false},{"year":2018,"finding":"MMACHC is subject to epigenetic silencing: mutations in the adjacent PRDX1 gene force antisense transcription across the MMACHC locus, generating H3K36me3 marks and promoter hypermethylation (epimutation) that silences MMACHC. 5-azacytidine treatment restored MMACHC expression in fibroblasts. The epimutation was detected in blood, fibroblasts, and sperm and was transmitted across three generations.","method":"Bisulfite sequencing, methylation-specific PCR, 5-azacytidine rescue of expression, PRDX1 silencing experiments, ChIP for H3K36me3","journal":"Nature communications","confidence":"High","confidence_rationale":"Tier 2 — multiple orthogonal epigenetic methods, functional rescue, multigenerational evidence","pmids":["29302025"],"is_preprint":false},{"year":2009,"finding":"Epigenetic inactivation (promoter CpG island hypermethylation) of the MMACHC gene causes methionine dependence and a cblC-like cellular phenotype in the MeWo-LC1 melanoma cell line; retroviral infection with wild-type MMACHC corrected the cobalamin metabolism defect and restored growth on homocysteine, establishing that MMACHC loss drives this phenotype.","method":"Complementation analysis with cblC fibroblasts, bisulfite sequencing/methylation analysis of CpG island, quantitative PCR, retroviral MMACHC transduction","journal":"Molecular genetics and metabolism","confidence":"High","confidence_rationale":"Tier 2 — functional complementation plus epigenetic mechanism; multiple orthogonal methods","pmids":["19200761"],"is_preprint":false},{"year":2014,"finding":"Loss of HCFC1 ortholog hcfc1b in zebrafish causes craniofacial development defects through reduced mmachc expression; craniofacial abnormalities were rescued by expression of human MMACHC, placing MMACHC downstream of HCFC1/HCFC1B in a pathway required for craniofacial development.","method":"Zebrafish loss-of-function (hcfc1b morpholino), rescue with human MMACHC expression, neural crest cell differentiation/proliferation assays, human HCFC1 mutation analysis","journal":"Developmental biology","confidence":"High","confidence_rationale":"Tier 2 — genetic epistasis in zebrafish with rescue experiment; establishes pathway position","pmids":["25281006"],"is_preprint":false},{"year":2014,"finding":"Homozygous gene-trap inactivation of Mmachc in mice is lethal before embryonic day 3.5; heterozygous mice have 50% reduced MMACHC protein and significantly elevated homocysteine and methylmalonic acid, establishing that Mmachc is essential for pre-implantation embryogenesis and demonstrating dose-sensitivity in vivo.","method":"Gene-trap mouse model, Western blot for MMACHC protein quantification, metabolite measurements (plasma homocysteine and MMA), blastocyst outgrowth assay","journal":"Molecular genetics and metabolism","confidence":"High","confidence_rationale":"Tier 2 — clean KO with defined cellular and metabolic phenotype","pmids":["24889031"],"is_preprint":false},{"year":2020,"finding":"CblC (MMACHC) catalyzes GSH-dependent denitration of nitrocobalamin (NO2Cbl) forming 5-coordinate cob(II)alamin; this cob(II)alamin can be oxidized or enter a futile thiol oxidase cycle. CblC also exhibits nitrite reductase activity (converting cob(I)alamin and nitrite to NOCbl). The R161G disease variant stabilizes cob(II)alamin and promotes futile cycling. Denitration activity of CblC supported cell proliferation in the presence of NO2Cbl.","method":"In vitro enzymatic assays with purified recombinant CblC, UV-vis spectroscopy, cell proliferation assays in presence of NO2Cbl","journal":"The Journal of biological chemistry","confidence":"High","confidence_rationale":"Tier 1 — reconstituted in vitro assays with mutagenesis and cell-based functional validation","pmids":["32457044"],"is_preprint":false},{"year":2020,"finding":"Loss of mmachc function in zebrafish (CRISPR/Cas9 knockout) results in methylmalonic acidemia, severe growth retardation, and lethality in early juvenile life, recapitulating human cblC disease. Retinopathy and thin optic nerves were observed; metabolic and morphological parameters improved with hydroxocobalamin, methylcobalamin, methionine, and betaine supplementation.","method":"CRISPR/Cas9 genome editing, metabolite measurements, morphological and retinal phenotyping, fluorescent reporter lines, pharmacological rescue","journal":"Human molecular genetics","confidence":"High","confidence_rationale":"Tier 2 — clean KO with defined metabolic and ocular phenotypes, pharmacological rescue","pmids":["32186706"],"is_preprint":false},{"year":2013,"finding":"The deletion mutation MMACHC-Gln131del (c.392_394del) results in a folded but perturbed protein with reduced enzymatic activity; structural analysis showed Gln131 makes hydrogen bonds to the tail of cobalamin, and its deletion reduces cobalamin binding and enzyme activity as shown by spectroscopic assays on recombinant protein and patient fibroblast studies.","method":"Recombinant protein spectroscopic activity assays, circular dichroism spectroscopy, fibroblast complementation studies","journal":"JIMD reports","confidence":"Medium","confidence_rationale":"Tier 1 — in vitro structural and enzymatic characterization; single study","pmids":["23580368"],"is_preprint":false},{"year":2022,"finding":"Biophysical analysis of the disease-associated MMACHC-R132X truncation mutant (from c.394C>T) showed it retains secondary structure and remains compact in solution, partly preserving cobalamin binding affinity, consistent with residual function associated with late-onset disease phenotype.","method":"Circular dichroism, fluorescence spectroscopy, small angle X-ray scattering (SAXS), molecular dynamics","journal":"Biochimica et biophysica acta. Proteins and proteomics","confidence":"Medium","confidence_rationale":"Tier 1 — multiple biophysical methods; single study, no functional enzymatic assay","pmids":["35618206"],"is_preprint":false},{"year":2022,"finding":"MMACHC transcription is repressed by hypoxia; this repression is partially mediated by HIF1A and the microRNA biogenesis factor DROSHA (whose knockdowns additively released repression), but not through the known HCFC1/THAP11/ZNF143 transcription factor complex.","method":"Hypoxia exposure of multiple cell lines and mouse tissues, RT-qPCR, RNA interference against HIF1A, HIF2A, REST, DROSHA","journal":"Biochimica et biophysica acta. General subjects","confidence":"Medium","confidence_rationale":"Tier 2 — RNAi in multiple cell lines; single lab, mechanism partially defined","pmids":["35636712"],"is_preprint":false},{"year":2020,"finding":"Thiolatocobalamins (cysteaminylcobalamin and 2-mercaptopropionylglycinocobalamin) bind to human CblC and undergo GSH-dependent dethiolation; they can repair the loss of dealkylation activity of pathogenic CblC variants R161G and R161Q, as the spontaneous dethiolation rate is orders of magnitude faster than alkylcobalamin dealkylation.","method":"In vitro binding and dethiolation kinetics with purified recombinant wild-type and mutant human CblC, UV-vis spectroscopy","journal":"Biochimie","confidence":"Medium","confidence_rationale":"Tier 1 — in vitro reconstituted assays; single study, no cell-based validation","pmids":["33190793"],"is_preprint":false},{"year":2011,"finding":"cblC patient fibroblasts show increased export of homocysteine and methylmalonic acid, decreased total intracellular folates, and broad proteome changes (cytoskeletal, neurological, and signaling proteins) compared to controls; hydroxocobalamin supplementation did not restore the proteome to control patterns.","method":"2D-DIGE and LC/ESI/MS proteomics of control vs. cblC fibroblasts, metabolite measurements","journal":"Molecular genetics and metabolism","confidence":"Medium","confidence_rationale":"Tier 2 — quantitative proteomics with defined loss-of-function; single lab","pmids":["21497120"],"is_preprint":false},{"year":2021,"finding":"Peripheral retinal neurons do not require intrinsic MMACHC expression for survival and function; conditional deletion of Mmachc in peripheral retinal cells in mice led to accumulation of MMA and folate-cycle intermediates but did not cause retinal morphological or functional defects, suggesting the retinal phenotype in cblC patients is not due to local MMACHC deficiency.","method":"Conditional Mmachc knockout mouse (Cre-lox), metabolite quantification in retina, fundus imaging, electroretinography, retinal histology","journal":"Biochimica et biophysica acta. Molecular basis of disease","confidence":"Medium","confidence_rationale":"Tier 2 — clean conditional KO with multi-modal retinal phenotyping; single study","pmids":["34147638"],"is_preprint":false},{"year":2023,"finding":"In a zebrafish cblC model (mmachc hg13 mutant), homozygous mutation causes abnormal chondrocyte nuclear organization and increased neighboring cell contacts; both phenotypes were fully rescued by wild-type MMACHC and by a cobalamin-binding–deficient MMACHC variant, indicating these craniofacial defects are independent of cobalamin binding.","method":"Zebrafish genetic model, rescue experiments with wild-type and cobalamin-binding mutant MMACHC, chondrocyte morphological analysis, neural crest marker localization","journal":"Differentiation; research in biological diversity","confidence":"Medium","confidence_rationale":"Tier 2 — genetic rescue with separation-of-function mutant; single study","pmids":["37167860"],"is_preprint":false}],"current_model":"MMACHC (CblC) is a cytoplasmic multifunctional processing chaperone that removes the upper axial ligand from all dietary and supplemental cobalamin derivatives—catalyzing FMN/NADPH-dependent reductive decyanation of cyanocobalamin and GSH-dependent dealkylation of alkylcobalamins—via a nitroreductase scaffold that binds cobalamin in a 'base-off' configuration with an arginine-rich pocket coordinating GSH; it functions as a domain-swapped dimer and acts in a multiprotein complex with MMADHC, methionine synthase, and methionine synthase reductase to generate cob(II)alamin for downstream delivery to adenosylcobalamin and methylcobalamin synthesis pathways, with disease mutations either abolishing cobalamin binding, impairing dealkylation and destabilizing the protein, or promoting futile thiol oxidase cycling that increases cellular oxidative stress."},"narrative":{"teleology":[{"year":2005,"claim":"Identification of MMACHC as the cblC disease gene resolved a decades-long search for the genetic basis of the most common inborn error of intracellular cobalamin metabolism, establishing that this single gene is required for synthesis of both adenosylcobalamin and methylcobalamin.","evidence":"Homozygosity mapping and mutation identification in 204 patients, with retroviral complementation of cblC fibroblasts","pmids":["16311595"],"confidence":"High","gaps":["Enzymatic mechanism unknown at this stage","Subcellular localization not determined","Protein partners not identified"]},{"year":2009,"claim":"Demonstration that MMACHC catalyzes both decyanation of cyanocobalamin (NADPH/FAD-dependent) and dealkylation of naturally occurring alkylcobalamins, with base-off CNCbl binding, defined the dual enzymatic activities and cofactor requirements of the protein.","evidence":"Radioisotopic substrate conversion in patient vs. control fibroblasts, in vitro enzymatic and binding assays with recombinant protein and cobalamin ligands","pmids":["19447654","19700356"],"confidence":"High","gaps":["Three-dimensional structure not yet available","Mechanism of GSH involvement in dealkylation unknown","Protein interaction network not characterized"]},{"year":2010,"claim":"Biophysical characterization revealed that apo-MMACHC is thermolabile and stabilized by cobalamin binding, while identification of MMADHC as a direct physical partner established the first component of a cobalamin processing relay.","evidence":"Differential scanning fluorimetry of wild-type and R161Q proteins with cobalamin ligands; surface plasmon resonance and bacterial two-hybrid for MMACHC–MMADHC interaction","pmids":["20219402","21071249"],"confidence":"High","gaps":["Structural basis of MMACHC–MMADHC interaction unknown","Whether MMACHC functions as monomer or oligomer unclear","Interaction with methionine synthase not yet tested"]},{"year":2012,"claim":"The crystal structure of MMACHC bound to AdoCbl revealed a nitroreductase scaffold with a domain-swapped dimer architecture and an arginine-rich GSH-binding pocket, providing the structural basis for dealkylation catalysis and explaining why Arg161 mutations cause disease; concurrent localization studies confirmed exclusive cytoplasmic residence.","evidence":"X-ray crystallography with site-directed mutagenesis and dealkylation assays; immunofluorescence and subcellular fractionation with retroviral complementation","pmids":["22642810","23270877","22832074"],"confidence":"High","gaps":["Structural basis of the MMACHC–MMADHC heterodimer not resolved","Mechanism of cobalamin handoff to downstream partners unknown","Decyanation reaction mechanism at atomic level not defined"]},{"year":2013,"claim":"Discovery that methionine synthase is a direct MMACHC-binding partner, with disease mutations R161Q and R206W disrupting this interaction, expanded the processing model from a two-protein relay to a multi-component complex enabling direct cofactor delivery.","evidence":"Co-immunoprecipitation and proximity ligation assay in multiple cell lines with 3D docking models","pmids":["23825108","23415655"],"confidence":"High","gaps":["Methionine synthase reductase (MSR) role in the complex not yet defined","Stoichiometry and assembly order of the full complex unknown","Whether complex formation is cobalamin-dependent in cells not established"]},{"year":2014,"claim":"Mouse knockout revealed that Mmachc is essential for pre-implantation embryogenesis with haploinsufficiency causing metabolic perturbations, while zebrafish studies placed MMACHC downstream of HCFC1 in craniofacial development, defining in vivo requirements beyond cobalamin metabolism.","evidence":"Gene-trap mouse model with metabolite measurements; zebrafish hcfc1b morpholino with human MMACHC rescue","pmids":["24889031","25281006"],"confidence":"High","gaps":["Mechanism of MMACHC's role in craniofacial development beyond cobalamin processing unclear","Conditional tissue-specific requirements not systematically mapped","Whether craniofacial phenotype is cobalamin-dependent or independent not resolved"]},{"year":2015,"claim":"Structural resolution of the MMACHC–MMADHC heterodimer by SAXS, together with the finding that Arg161 mutations selectively impair dealkylation while unmasking futile thiol oxidase cycling, provided a mechanistic framework linking genotype to disease severity and oxidative stress.","evidence":"SAXS of 1:1 heterodimer and crystal structure of MMADHC; in vitro dealkylation, decyanation, GSH binding, and thiol oxidase assays with R161Q/R161G mutants","pmids":["26483544","25809485"],"confidence":"High","gaps":["Atomic-resolution structure of intact MMACHC–MMADHC complex not available","In vivo contribution of thiol oxidase activity to patient pathology not quantified","Mechanism controlling whether cob(II)alamin enters productive vs. futile cycle not defined"]},{"year":2016,"claim":"Identification of MSR–MMACHC and MSR–MMADHC interactions completed the picture of a four-protein cytoplasmic cobalamin processing complex (MMACHC–MMADHC–MS–MSR), where loss of any core member disrupts complex assembly.","evidence":"Co-immunoprecipitation and proximity ligation assays in patient fibroblasts with cblC, cblG, and cblE defects, and siRNA-transfected HepG2 cells","pmids":["27771510"],"confidence":"High","gaps":["Whether complex is constitutive or cobalamin-regulated in vivo unknown","No reconstitution of full four-protein complex in vitro","Kinetic pathway of cobalamin transfer through complex not defined"]},{"year":2017,"claim":"Crystal structures of MMACHC with an antivitamin B12 analogue and characterization of C. elegans CblC defined the active-site architecture for GSH-dependent catalysis and established that thiol oxidase activity proceeds through a glutathionyl-cobalamin intermediate.","evidence":"Crystal structures of human CblC–antivitamin–GSH ternary complex and C. elegans CblC; in vitro thiol oxidase assays with EPR spectroscopy","pmids":["28544088","28442570"],"confidence":"High","gaps":["No time-resolved structural data capturing catalytic intermediates during dealkylation","Physiological regulation of thiol oxidase activity not characterized","No structural data for decyanation reaction mechanism"]},{"year":2018,"claim":"Discovery that MMACHC can be epigenetically silenced by antisense transcription-induced promoter methylation originating from the adjacent PRDX1 locus, with transgenerational inheritance, established a non-Mendelian mechanism for cblC disease.","evidence":"Bisulfite sequencing, ChIP for H3K36me3, 5-azacytidine rescue of expression, multigenerational pedigree analysis","pmids":["29302025"],"confidence":"High","gaps":["Frequency of epimutation among cblC patients not systematically determined","Mechanism of transgenerational epigenetic escape from reprogramming unknown","Whether other loci can similarly silence MMACHC not explored"]},{"year":2020,"claim":"Extension of MMACHC's substrate repertoire to nitrocobalamin and thiolatocobalamins broadened the catalytic scope and demonstrated that thiolatocobalamins can bypass dealkylation defects in R161 mutants, suggesting therapeutic avenues.","evidence":"In vitro denitration and dethiolation assays with recombinant wild-type and mutant CblC; cell proliferation assays with NO2Cbl","pmids":["32457044","33190793"],"confidence":"High","gaps":["No cell-based validation of thiolatocobalamin rescue of disease mutations","In vivo relevance of nitrocobalamin processing not established","Pharmacokinetics of thiolatocobalamins not evaluated"]},{"year":2023,"claim":"Zebrafish rescue experiments with a cobalamin-binding-deficient MMACHC variant demonstrated that certain craniofacial developmental functions of MMACHC are independent of its cobalamin processing activity, revealing a potential non-canonical role.","evidence":"Zebrafish mmachc mutant rescue with wild-type and cobalamin-binding-deficient MMACHC; chondrocyte morphological analysis","pmids":["37167860"],"confidence":"Medium","gaps":["Molecular basis of the cobalamin-independent function completely undefined","No mammalian validation","Binding partners mediating this non-canonical function not identified"]},{"year":null,"claim":"Key unresolved questions include the atomic-resolution structure of the full MMACHC–MMADHC–MS–MSR complex, the kinetic mechanism of cobalamin handoff between complex members, the molecular basis of MMACHC's cobalamin-independent developmental roles, and whether therapeutic modulation of the thiol oxidase side reaction can ameliorate cblC disease.","evidence":"","pmids":[],"confidence":"Low","gaps":["No reconstituted in vitro transfer assay for the full four-protein complex","Cobalamin-independent function mechanism entirely unknown","No structural data for the intact multiprotein processing complex"]}],"mechanism_profile":{"molecular_activity":[{"term_id":"GO:0140096","term_label":"catalytic activity, acting on a protein","supporting_discovery_ids":[1,3,11,19]},{"term_id":"GO:0016491","term_label":"oxidoreductase activity","supporting_discovery_ids":[2,3,14,19]},{"term_id":"GO:0016787","term_label":"hydrolase activity","supporting_discovery_ids":[1,11]}],"localization":[{"term_id":"GO:0005829","term_label":"cytosol","supporting_discovery_ids":[6,12]}],"pathway":[],"complexes":["MMACHC-MMADHC-MS-MSR cobalamin processing complex"],"partners":["MMADHC","MTR","MTRR","HCFC1"],"other_free_text":[]},"mechanistic_narrative":"MMACHC is a cytoplasmic cobalamin (vitamin B12) processing enzyme that catalyzes removal of the upper axial ligand from all dietary cobalamin derivatives, serving as the essential first step in intracellular generation of the cofactors adenosylcobalamin and methylcobalamin [PMID:16311595, PMID:19447654]. It adopts a nitroreductase fold that binds cobalamin in a base-off configuration as a domain-swapped dimer, performing FMN/NADPH-dependent reductive decyanation of cyanocobalamin and GSH-dependent dealkylation of alkylcobalamins through an arginine-rich active site that coordinates glutathione [PMID:22642810, PMID:19700356]. MMACHC operates within a cytoplasmic multiprotein complex with MMADHC, methionine synthase, and methionine synthase reductase, where MMADHC acts downstream to partition processed cob(II)alamin between cytoplasmic and mitochondrial cofactor synthesis pathways [PMID:27771510, PMID:23415655]. Biallelic loss-of-function mutations in MMACHC cause cblC-type combined methylmalonic aciduria and homocystinuria, with disease-associated mutations at Arg161 selectively impairing dealkylation and GSH binding while unmasking a futile thiol oxidase activity that promotes oxidative stress [PMID:16311595, PMID:25809485, PMID:28442570]."},"prefetch_data":{"uniprot":{"accession":"Q9Y4U1","full_name":"Cyanocobalamin reductase / alkylcobalamin dealkylase","aliases":["Alkylcobalamin:glutathione S-alkyltransferase","CblC","Cyanocobalamin reductase (cyanide-eliminating)","Methylmalonic aciduria and homocystinuria type C protein","MMACHC"],"length_aa":282,"mass_kda":31.7,"function":"Cobalamin (vitamin B12) cytosolic chaperone that catalyzes the reductive decyanation of cyanocob(III)alamin (cyanocobalamin, CNCbl) to yield cob(II)alamin and cyanide, using FAD or FMN as cofactors and NADPH as cosubstrate (PubMed:18779575, PubMed:19700356, PubMed:21697092, PubMed:25809485). Cyanocobalamin constitutes the inactive form of vitamin B12 introduced from the diet, and is converted into the active cofactors methylcobalamin (MeCbl) involved in methionine biosynthesis, and 5'-deoxyadenosylcobalamin (AdoCbl) involved in the TCA cycle (PubMed:19801555). Forms a complex with the lysosomal transporter ABCD4 and its chaperone LMBRD1, to transport cobalamin across the lysosomal membrane into the cytosol (PubMed:25535791). The processing of cobalamin in the cytosol occurs in a multiprotein complex composed of at least MMACHC, MMADHC, MTRR (methionine synthase reductase) and MTR (methionine synthase) which may contribute to shuttle safely and efficiently cobalamin towards MTR in order to produce methionine (PubMed:21071249, PubMed:27771510). Also acts as a glutathione transferase by catalyzing the dealkylation of the alkylcob(III)alamins MeCbl and AdoCbl, using the thiolate of glutathione for nucleophilic displacement to generate cob(I)alamin and the corresponding glutathione thioether (PubMed:19801555, PubMed:21697092, PubMed:22642810, PubMed:25809485). The conversion of incoming MeCbl or AdoCbl into a common intermediate cob(I)alamin is necessary to meet the cellular needs for both cofactors (PubMed:19801555). Cysteine and homocysteine cannot substitute for glutathione in this reaction (PubMed:19801555)","subcellular_location":"Cytoplasm, cytosol","url":"https://www.uniprot.org/uniprotkb/Q9Y4U1/entry"},"depmap":{"release":"DepMap","has_data":true,"is_common_essential":false,"resolved_as":"","url":"https://depmap.org/portal/gene/MMACHC","classification":"Not Classified","n_dependent_lines":44,"n_total_lines":1208,"dependency_fraction":0.03642384105960265},"opencell":{"profiled":false,"resolved_as":"","ensg_id":"","cell_line_id":"","localizations":[],"interactors":[],"url":"https://opencell.sf.czbiohub.org/search/MMACHC","total_profiled":1310},"omim":[{"mim_id":"620940","title":"METHYLMALONIC ACIDURIA AND HOMOCYSTINURIA, cblL TYPE; MAHCL","url":"https://www.omim.org/entry/620940"},{"mim_id":"609831","title":"METABOLISM OF COBALAMIN ASSOCIATED C; MMACHC","url":"https://www.omim.org/entry/609831"},{"mim_id":"609119","title":"THAP DOMAIN-CONTAINING PROTEIN 11; THAP11","url":"https://www.omim.org/entry/609119"},{"mim_id":"603433","title":"ZINC FINGER PROTEIN 143; ZNF143","url":"https://www.omim.org/entry/603433"},{"mim_id":"309541","title":"METHYLMALONIC ACIDURIA AND HOMOCYSTINURIA, cblX TYPE; MAHCX","url":"https://www.omim.org/entry/309541"}],"hpa":{"profiled":true,"resolved_as":"","reliability":"Supported","locations":[{"location":"Nucleoplasm","reliability":"Supported"},{"location":"Plasma membrane","reliability":"Additional"},{"location":"Cytosol","reliability":"Additional"}],"tissue_specificity":"Tissue enhanced","tissue_distribution":"Detected in all","driving_tissues":[{"tissue":"liver","ntpm":16.2}],"url":"https://www.proteinatlas.org/search/MMACHC"},"hgnc":{"alias_symbol":["DKFZP564I122","cblC"],"prev_symbol":[]},"alphafold":{"accession":"Q9Y4U1","domains":[{"cath_id":"-","chopping":"4-235","consensus_level":"high","plddt":95.3744,"start":4,"end":235}],"viewer_url":"https://alphafold.ebi.ac.uk/entry/Q9Y4U1","model_url":"https://alphafold.ebi.ac.uk/files/AF-Q9Y4U1-F1-model_v6.cif","pae_url":"https://alphafold.ebi.ac.uk/files/AF-Q9Y4U1-F1-predicted_aligned_error_v6.png","plddt_mean":85.62},"mouse_models":{"mgi_url":"https://www.informatics.jax.org/marker/summary?nomen=MMACHC","jax_strain_url":"https://www.jax.org/strain/search?query=MMACHC"},"sequence":{"accession":"Q9Y4U1","fasta_url":"https://rest.uniprot.org/uniprotkb/Q9Y4U1.fasta","uniprot_url":"https://www.uniprot.org/uniprotkb/Q9Y4U1/entry","alphafold_viewer_url":"https://alphafold.ebi.ac.uk/entry/Q9Y4U1"}},"corpus_meta":[{"pmid":"16311595","id":"PMC_16311595","title":"Identification of the gene responsible for methylmalonic aciduria and homocystinuria, cblC type.","date":"2005","source":"Nature genetics","url":"https://pubmed.ncbi.nlm.nih.gov/16311595","citation_count":303,"is_preprint":false},{"pmid":"21748409","id":"PMC_21748409","title":"Combined methylmalonic acidemia and homocystinuria, cblC type. I. Clinical presentations, diagnosis and management.","date":"2011","source":"Journal of inherited metabolic disease","url":"https://pubmed.ncbi.nlm.nih.gov/21748409","citation_count":176,"is_preprint":false},{"pmid":"19370762","id":"PMC_19370762","title":"Spectrum of mutations in MMACHC, allelic expression, and evidence for genotype-phenotype correlations.","date":"2009","source":"Human mutation","url":"https://pubmed.ncbi.nlm.nih.gov/19370762","citation_count":159,"is_preprint":false},{"pmid":"24599607","id":"PMC_24599607","title":"Clinical presentation and outcome in a series of 88 patients with the cblC defect.","date":"2014","source":"Journal of inherited metabolic disease","url":"https://pubmed.ncbi.nlm.nih.gov/24599607","citation_count":135,"is_preprint":false},{"pmid":"16714133","id":"PMC_16714133","title":"Combined methylmalonic aciduria and homocystinuria (cblC): phenotype-genotype correlations and ethnic-specific observations.","date":"2006","source":"Molecular genetics and metabolism","url":"https://pubmed.ncbi.nlm.nih.gov/16714133","citation_count":112,"is_preprint":false},{"pmid":"19447654","id":"PMC_19447654","title":"Processing of alkylcobalamins in mammalian cells: A role for the MMACHC (cblC) gene product.","date":"2009","source":"Molecular genetics and metabolism","url":"https://pubmed.ncbi.nlm.nih.gov/19447654","citation_count":102,"is_preprint":false},{"pmid":"18164228","id":"PMC_18164228","title":"Spectrum of MMACHC mutations in Italian and Portuguese patients with combined methylmalonic aciduria and homocystinuria, cblC type.","date":"2007","source":"Molecular genetics and metabolism","url":"https://pubmed.ncbi.nlm.nih.gov/18164228","citation_count":81,"is_preprint":false},{"pmid":"20631720","id":"PMC_20631720","title":"Mutation spectrum of MMACHC in Chinese patients with combined methylmalonic aciduria and homocystinuria.","date":"2010","source":"Journal of human genetics","url":"https://pubmed.ncbi.nlm.nih.gov/20631720","citation_count":80,"is_preprint":false},{"pmid":"17874135","id":"PMC_17874135","title":"Hemolytic uremic syndrome (HUS) secondary to cobalamin C (cblC) disorder.","date":"2007","source":"Pediatric nephrology (Berlin, Germany)","url":"https://pubmed.ncbi.nlm.nih.gov/17874135","citation_count":79,"is_preprint":false},{"pmid":"19760748","id":"PMC_19760748","title":"Genetic and cellular studies of oxidative stress in methylmalonic aciduria (MMA) cobalamin deficiency type C (cblC) with homocystinuria (MMACHC).","date":"2009","source":"Human mutation","url":"https://pubmed.ncbi.nlm.nih.gov/19760748","citation_count":76,"is_preprint":false},{"pmid":"12226085","id":"PMC_12226085","title":"Interaction between two ubiquitin-protein isopeptide ligases of different classes, CBLC and AIP4/ITCH.","date":"2002","source":"The Journal of biological chemistry","url":"https://pubmed.ncbi.nlm.nih.gov/12226085","citation_count":73,"is_preprint":false},{"pmid":"20924684","id":"PMC_20924684","title":"Clinical, biochemical, and molecular analysis of combined methylmalonic acidemia and hyperhomocysteinemia (cblC type) in China.","date":"2010","source":"Journal of inherited metabolic disease","url":"https://pubmed.ncbi.nlm.nih.gov/20924684","citation_count":71,"is_preprint":false},{"pmid":"29302025","id":"PMC_29302025","title":"APRDX1 mutant allele causes a MMACHC secondary epimutation in cblC patients.","date":"2018","source":"Nature communications","url":"https://pubmed.ncbi.nlm.nih.gov/29302025","citation_count":69,"is_preprint":false},{"pmid":"17853453","id":"PMC_17853453","title":"Late-onset combined homocystinuria and methylmalonic aciduria (cblC) and neuropsychiatric disturbance.","date":"2007","source":"American journal of medical genetics. Part A","url":"https://pubmed.ncbi.nlm.nih.gov/17853453","citation_count":54,"is_preprint":false},{"pmid":"10571044","id":"PMC_10571044","title":"Molecular cloning and characterization of a novel cbl-family gene, cbl-c.","date":"1999","source":"Gene","url":"https://pubmed.ncbi.nlm.nih.gov/10571044","citation_count":54,"is_preprint":false},{"pmid":"19767224","id":"PMC_19767224","title":"High prevalence of structural heart disease in children with cblC-type methylmalonic aciduria and homocystinuria.","date":"2009","source":"Molecular genetics and metabolism","url":"https://pubmed.ncbi.nlm.nih.gov/19767224","citation_count":52,"is_preprint":false},{"pmid":"15754282","id":"PMC_15754282","title":"Late-onset thrombocytic microangiopathy caused by cblC disease: association with a factor H mutation.","date":"2005","source":"American journal of kidney diseases : the official journal of the National Kidney Foundation","url":"https://pubmed.ncbi.nlm.nih.gov/15754282","citation_count":52,"is_preprint":false},{"pmid":"14661060","id":"PMC_14661060","title":"Cbl-c suppresses v-Src-induced transformation through ubiquitin-dependent protein degradation.","date":"2004","source":"Oncogene","url":"https://pubmed.ncbi.nlm.nih.gov/14661060","citation_count":52,"is_preprint":false},{"pmid":"26563984","id":"PMC_26563984","title":"Clinical presentation, gene analysis and outcomes in young patients with early-treated combined methylmalonic acidemia and homocysteinemia (cblC type) in Shandong province, China.","date":"2015","source":"Brain & development","url":"https://pubmed.ncbi.nlm.nih.gov/26563984","citation_count":50,"is_preprint":false},{"pmid":"22642810","id":"PMC_22642810","title":"Structure of MMACHC reveals an arginine-rich pocket and a domain-swapped dimer for its B12 processing function.","date":"2012","source":"Biochemistry","url":"https://pubmed.ncbi.nlm.nih.gov/22642810","citation_count":48,"is_preprint":false},{"pmid":"20219402","id":"PMC_20219402","title":"Thermolability of mutant MMACHC protein in the vitamin B12-responsive cblC disorder.","date":"2010","source":"Molecular genetics and metabolism","url":"https://pubmed.ncbi.nlm.nih.gov/20219402","citation_count":47,"is_preprint":false},{"pmid":"29945960","id":"PMC_29945960","title":"Upregulation of E3 Ubiquitin Ligase CBLC Enhances EGFR Dysregulation and Signaling in Lung Adenocarcinoma.","date":"2018","source":"Cancer research","url":"https://pubmed.ncbi.nlm.nih.gov/29945960","citation_count":47,"is_preprint":false},{"pmid":"19700356","id":"PMC_19700356","title":"Mechanism of vitamin B12-responsiveness in cblC methylmalonic aciduria with homocystinuria.","date":"2009","source":"Molecular genetics and metabolism","url":"https://pubmed.ncbi.nlm.nih.gov/19700356","citation_count":45,"is_preprint":false},{"pmid":"31279840","id":"PMC_31279840","title":"Mutation spectrum of MMACHC in Chinese pediatric patients with cobalamin C disease: A case series and literature review.","date":"2019","source":"European journal of medical genetics","url":"https://pubmed.ncbi.nlm.nih.gov/31279840","citation_count":42,"is_preprint":false},{"pmid":"26483544","id":"PMC_26483544","title":"Structural Insights into the MMACHC-MMADHC Protein Complex Involved in Vitamin B12 Trafficking.","date":"2015","source":"The Journal of biological chemistry","url":"https://pubmed.ncbi.nlm.nih.gov/26483544","citation_count":39,"is_preprint":false},{"pmid":"21071249","id":"PMC_21071249","title":"Interaction between MMACHC and MMADHC, two human proteins participating in intracellular vitamin B₁₂ metabolism.","date":"2010","source":"Molecular genetics and metabolism","url":"https://pubmed.ncbi.nlm.nih.gov/21071249","citation_count":39,"is_preprint":false},{"pmid":"25281006","id":"PMC_25281006","title":"Hcfc1b, a zebrafish ortholog of HCFC1, regulates craniofacial development by modulating mmachc expression.","date":"2014","source":"Developmental biology","url":"https://pubmed.ncbi.nlm.nih.gov/25281006","citation_count":36,"is_preprint":false},{"pmid":"32746869","id":"PMC_32746869","title":"Variable phenotypes and outcomes associated with the MMACHC c.609G>A homologous mutation: long term follow-up in a large cohort of cases.","date":"2020","source":"Orphanet journal of rare diseases","url":"https://pubmed.ncbi.nlm.nih.gov/32746869","citation_count":35,"is_preprint":false},{"pmid":"23415655","id":"PMC_23415655","title":"The C-terminal domain of CblD interacts with CblC and influences intracellular cobalamin partitioning.","date":"2013","source":"Biochimie","url":"https://pubmed.ncbi.nlm.nih.gov/23415655","citation_count":34,"is_preprint":false},{"pmid":"25809485","id":"PMC_25809485","title":"Pathogenic mutations differentially affect the catalytic activities of the human B12-processing chaperone CblC and increase futile redox cycling.","date":"2015","source":"The Journal of biological chemistry","url":"https://pubmed.ncbi.nlm.nih.gov/25809485","citation_count":34,"is_preprint":false},{"pmid":"24853097","id":"PMC_24853097","title":"Reversible pulmonary arterial hypertension in cobalamin-dependent cobalamin C disease due to a novel mutation in the MMACHC gene.","date":"2014","source":"European journal of pediatrics","url":"https://pubmed.ncbi.nlm.nih.gov/24853097","citation_count":34,"is_preprint":false},{"pmid":"20525694","id":"PMC_20525694","title":"The N terminus of Cbl-c regulates ubiquitin ligase activity by modulating affinity for the ubiquitin-conjugating enzyme.","date":"2010","source":"The Journal of biological chemistry","url":"https://pubmed.ncbi.nlm.nih.gov/20525694","citation_count":34,"is_preprint":false},{"pmid":"21497120","id":"PMC_21497120","title":"The MMACHC proteome: hallmarks of functional cobalamin deficiency in humans.","date":"2011","source":"Molecular genetics and metabolism","url":"https://pubmed.ncbi.nlm.nih.gov/21497120","citation_count":34,"is_preprint":false},{"pmid":"22560872","id":"PMC_22560872","title":"A clinical and gene analysis of late-onset combined methylmalonic aciduria and homocystinuria, cblC type, in China.","date":"2012","source":"Journal of the neurological sciences","url":"https://pubmed.ncbi.nlm.nih.gov/22560872","citation_count":33,"is_preprint":false},{"pmid":"25585586","id":"PMC_25585586","title":"The proteome of cblC defect: in vivo elucidation of altered cellular pathways in humans.","date":"2015","source":"Journal of inherited metabolic disease","url":"https://pubmed.ncbi.nlm.nih.gov/25585586","citation_count":31,"is_preprint":false},{"pmid":"35109910","id":"PMC_35109910","title":"Adult-onset CblC deficiency: a challenging diagnosis involving different adult clinical specialists.","date":"2022","source":"Orphanet journal of rare diseases","url":"https://pubmed.ncbi.nlm.nih.gov/35109910","citation_count":30,"is_preprint":false},{"pmid":"30157807","id":"PMC_30157807","title":"Molecular genetic characterization of cblC defects in 126 pedigrees and prenatal genetic diagnosis of pedigrees with combined methylmalonic aciduria and homocystinuria.","date":"2018","source":"BMC medical genetics","url":"https://pubmed.ncbi.nlm.nih.gov/30157807","citation_count":30,"is_preprint":false},{"pmid":"28544088","id":"PMC_28544088","title":"Antivitamin B12 Inhibition of the Human B12 -Processing Enzyme CblC: Crystal Structure of an Inactive Ternary Complex with Glutathione as the Cosubstrate.","date":"2017","source":"Angewandte Chemie (International ed. in English)","url":"https://pubmed.ncbi.nlm.nih.gov/28544088","citation_count":30,"is_preprint":false},{"pmid":"27771510","id":"PMC_27771510","title":"Methionine synthase and methionine synthase reductase interact with MMACHC and with MMADHC.","date":"2016","source":"Biochimica et biophysica acta. Molecular basis of disease","url":"https://pubmed.ncbi.nlm.nih.gov/27771510","citation_count":29,"is_preprint":false},{"pmid":"22832074","id":"PMC_22832074","title":"Structural features of recombinant MMADHC isoforms and their interactions with MMACHC, proteins of mammalian vitamin B12 metabolism.","date":"2012","source":"Molecular genetics and metabolism","url":"https://pubmed.ncbi.nlm.nih.gov/22832074","citation_count":29,"is_preprint":false},{"pmid":"32186706","id":"PMC_32186706","title":"The vitamin B12 processing enzyme, mmachc, is essential for zebrafish survival, growth and retinal morphology.","date":"2020","source":"Human molecular genetics","url":"https://pubmed.ncbi.nlm.nih.gov/32186706","citation_count":27,"is_preprint":false},{"pmid":"23825108","id":"PMC_23825108","title":"Interaction between methionine synthase isoforms and MMACHC: characterization in cblG-variant, cblG and cblC inherited causes of megaloblastic anaemia.","date":"2013","source":"Human molecular genetics","url":"https://pubmed.ncbi.nlm.nih.gov/23825108","citation_count":26,"is_preprint":false},{"pmid":"35242167","id":"PMC_35242167","title":"The Follow-Up of Chinese Patients in cblC Type Methylmalonic Acidemia Identified Through Expanded Newborn Screening.","date":"2022","source":"Frontiers in genetics","url":"https://pubmed.ncbi.nlm.nih.gov/35242167","citation_count":24,"is_preprint":false},{"pmid":"19200761","id":"PMC_19200761","title":"Epigenetic modification of the gene for the vitamin B(12) chaperone MMACHC can result in increased tumorigenicity and methionine dependence.","date":"2009","source":"Molecular genetics and metabolism","url":"https://pubmed.ncbi.nlm.nih.gov/19200761","citation_count":24,"is_preprint":false},{"pmid":"23270877","id":"PMC_23270877","title":"Subcellular location of MMACHC and MMADHC, two human proteins central to intracellular vitamin B(12) metabolism.","date":"2012","source":"Molecular genetics and metabolism","url":"https://pubmed.ncbi.nlm.nih.gov/23270877","citation_count":22,"is_preprint":false},{"pmid":"28442570","id":"PMC_28442570","title":"Coordination chemistry controls the thiol oxidase activity of the B12-trafficking protein CblC.","date":"2017","source":"The Journal of biological chemistry","url":"https://pubmed.ncbi.nlm.nih.gov/28442570","citation_count":22,"is_preprint":false},{"pmid":"20610126","id":"PMC_20610126","title":"Early onset methylmalonic aciduria and homocystinuria cblC type with demyelinating neuropathy.","date":"2010","source":"Pediatric neurology","url":"https://pubmed.ncbi.nlm.nih.gov/20610126","citation_count":21,"is_preprint":false},{"pmid":"24889031","id":"PMC_24889031","title":"The Mmachc gene is required for pre-implantation embryogenesis in the mouse.","date":"2014","source":"Molecular genetics and metabolism","url":"https://pubmed.ncbi.nlm.nih.gov/24889031","citation_count":19,"is_preprint":false},{"pmid":"25687216","id":"PMC_25687216","title":"Whole Exome Sequencing Identifies an Adult-Onset Case of Methylmalonic Aciduria and Homocystinuria Type C (cblC) with Non-Syndromic Bull's Eye Maculopathy.","date":"2015","source":"Ophthalmic genetics","url":"https://pubmed.ncbi.nlm.nih.gov/25687216","citation_count":19,"is_preprint":false},{"pmid":"32457044","id":"PMC_32457044","title":"The human B12 trafficking protein CblC processes nitrocobalamin.","date":"2020","source":"The Journal of biological chemistry","url":"https://pubmed.ncbi.nlm.nih.gov/32457044","citation_count":18,"is_preprint":false},{"pmid":"32941884","id":"PMC_32941884","title":"Mouse models to study the pathophysiology of combined methylmalonic acidemia and homocystinuria, cblC type.","date":"2020","source":"Developmental biology","url":"https://pubmed.ncbi.nlm.nih.gov/32941884","citation_count":18,"is_preprint":false},{"pmid":"17768669","id":"PMC_17768669","title":"Marfanoid features in a child with combined methylmalonic aciduria and homocystinuria (CblC type).","date":"2007","source":"Journal of inherited metabolic disease","url":"https://pubmed.ncbi.nlm.nih.gov/17768669","citation_count":18,"is_preprint":false},{"pmid":"23145173","id":"PMC_23145173","title":"Cbl-c ubiquitin ligase activity is increased via the interaction of its RING finger domain with a LIM domain of the paxillin homolog, Hic 5.","date":"2012","source":"PloS one","url":"https://pubmed.ncbi.nlm.nih.gov/23145173","citation_count":18,"is_preprint":false},{"pmid":"30564975","id":"PMC_30564975","title":"Hydrocephalus in cblC type methylmalonic acidemia.","date":"2018","source":"Metabolic brain disease","url":"https://pubmed.ncbi.nlm.nih.gov/30564975","citation_count":17,"is_preprint":false},{"pmid":"38245797","id":"PMC_38245797","title":"Late-onset methylmalonic acidemia and homocysteinemia (cblC disease): systematic review.","date":"2024","source":"Orphanet journal of rare diseases","url":"https://pubmed.ncbi.nlm.nih.gov/38245797","citation_count":16,"is_preprint":false},{"pmid":"29068997","id":"PMC_29068997","title":"Atypical hemolytic uremic syndrome induced by CblC subtype of methylmalonic academia: A case report and literature review.","date":"2017","source":"Medicine","url":"https://pubmed.ncbi.nlm.nih.gov/29068997","citation_count":16,"is_preprint":false},{"pmid":"25883215","id":"PMC_25883215","title":"Complementary genetic screens identify the E3 ubiquitin ligase CBLC, as a modifier of PARP inhibitor sensitivity.","date":"2015","source":"Oncotarget","url":"https://pubmed.ncbi.nlm.nih.gov/25883215","citation_count":16,"is_preprint":false},{"pmid":"35149839","id":"PMC_35149839","title":"Stabilization of AURKA by the E3 ubiquitin ligase CBLC in lung adenocarcinoma.","date":"2022","source":"Oncogene","url":"https://pubmed.ncbi.nlm.nih.gov/35149839","citation_count":15,"is_preprint":false},{"pmid":"20830523","id":"PMC_20830523","title":"Treatment of cobalamin C (cblC) deficiency during pregnancy.","date":"2010","source":"Journal of inherited metabolic disease","url":"https://pubmed.ncbi.nlm.nih.gov/20830523","citation_count":15,"is_preprint":false},{"pmid":"23580368","id":"PMC_23580368","title":"Novel Deletion Mutation Identified in a Patient with Late-Onset Combined Methylmalonic Acidemia and Homocystinuria, cblC Type.","date":"2013","source":"JIMD reports","url":"https://pubmed.ncbi.nlm.nih.gov/23580368","citation_count":14,"is_preprint":false},{"pmid":"34215320","id":"PMC_34215320","title":"PRDX1 gene-related epi-cblC disease is a common type of inborn error of cobalamin metabolism with mono- or bi-allelic MMACHC epimutations.","date":"2021","source":"Clinical epigenetics","url":"https://pubmed.ncbi.nlm.nih.gov/34215320","citation_count":14,"is_preprint":false},{"pmid":"36056359","id":"PMC_36056359","title":"Late-onset cblC deficiency around puberty: a retrospective study of the clinical characteristics, diagnosis, and treatment.","date":"2022","source":"Orphanet journal of rare diseases","url":"https://pubmed.ncbi.nlm.nih.gov/36056359","citation_count":13,"is_preprint":false},{"pmid":"33190793","id":"PMC_33190793","title":"Thiolatocobalamins repair the activity of pathogenic variants of the human cobalamin processing enzyme CblC.","date":"2020","source":"Biochimie","url":"https://pubmed.ncbi.nlm.nih.gov/33190793","citation_count":12,"is_preprint":false},{"pmid":"33487542","id":"PMC_33487542","title":"Methionine dependence in tumor cells: The potential role of cobalamin and MMACHC.","date":"2021","source":"Molecular genetics and metabolism","url":"https://pubmed.ncbi.nlm.nih.gov/33487542","citation_count":12,"is_preprint":false},{"pmid":"21536470","id":"PMC_21536470","title":"Expression of Mmachc and Mmadhc during mouse organogenesis.","date":"2011","source":"Molecular genetics and metabolism","url":"https://pubmed.ncbi.nlm.nih.gov/21536470","citation_count":12,"is_preprint":false},{"pmid":"20696242","id":"PMC_20696242","title":"Different altered pattern expression of genes related to apoptosis in isolated methylmalonic aciduria cblB type and combined with homocystinuria cblC type.","date":"2010","source":"Biochimica et biophysica acta","url":"https://pubmed.ncbi.nlm.nih.gov/20696242","citation_count":12,"is_preprint":false},{"pmid":"24974159","id":"PMC_24974159","title":"First Chinese case of successful pregnancy with combined methylmalonic aciduria and homocystinuria, cblC type.","date":"2014","source":"Brain & development","url":"https://pubmed.ncbi.nlm.nih.gov/24974159","citation_count":12,"is_preprint":false},{"pmid":"31260484","id":"PMC_31260484","title":"Loss of function Cbl-c mutations in solid tumors.","date":"2019","source":"PloS one","url":"https://pubmed.ncbi.nlm.nih.gov/31260484","citation_count":12,"is_preprint":false},{"pmid":"21835369","id":"PMC_21835369","title":"Combined methylmalonic aciduria and homocystinuria cblC type of a Taiwanese infant with c.609G>A and C.567dupT mutations in the MMACHC gene.","date":"2011","source":"Pediatrics and neonatology","url":"https://pubmed.ncbi.nlm.nih.gov/21835369","citation_count":12,"is_preprint":false},{"pmid":"35440018","id":"PMC_35440018","title":"Epimutations in both the TESK2 and MMACHC promoters in the Epi-cblC inherited disorder of intracellular metabolism of vitamin B12.","date":"2022","source":"Clinical epigenetics","url":"https://pubmed.ncbi.nlm.nih.gov/35440018","citation_count":11,"is_preprint":false},{"pmid":"22888118","id":"PMC_22888118","title":"Structural flexibility regulates phosphopeptide-binding activity of the tyrosine kinase binding domain of Cbl-c.","date":"2012","source":"Journal of biochemistry","url":"https://pubmed.ncbi.nlm.nih.gov/22888118","citation_count":11,"is_preprint":false},{"pmid":"35337623","id":"PMC_35337623","title":"Intracellular processing of vitamin B12 by MMACHC (CblC).","date":"2022","source":"Vitamins and hormones","url":"https://pubmed.ncbi.nlm.nih.gov/35337623","citation_count":10,"is_preprint":false},{"pmid":"31697851","id":"PMC_31697851","title":"Noninvasive prenatal diagnosis of cobalamin C (cblC) deficiency through target region sequencing of cell-free DNA in maternal plasma.","date":"2019","source":"Prenatal diagnosis","url":"https://pubmed.ncbi.nlm.nih.gov/31697851","citation_count":10,"is_preprint":false},{"pmid":"32198913","id":"PMC_32198913","title":"Rapid screening of MMACHC gene mutations by high-resolution melting curve analysis.","date":"2020","source":"Molecular genetics & genomic medicine","url":"https://pubmed.ncbi.nlm.nih.gov/32198913","citation_count":9,"is_preprint":false},{"pmid":"26149271","id":"PMC_26149271","title":"Prenatal diagnosis using genetic sequencing and identification of a novel mutation in MMACHC.","date":"2015","source":"BMC medical genetics","url":"https://pubmed.ncbi.nlm.nih.gov/26149271","citation_count":9,"is_preprint":false},{"pmid":"33515116","id":"PMC_33515116","title":"A high frequency and geographical distribution of MMACHC R132* mutation in children with cobalamin C defect.","date":"2021","source":"Amino acids","url":"https://pubmed.ncbi.nlm.nih.gov/33515116","citation_count":9,"is_preprint":false},{"pmid":"28481040","id":"PMC_28481040","title":"Optical coherence tomography morphology and evolution in cblC disease-related maculopathy in a case series of very young patients.","date":"2017","source":"Acta ophthalmologica","url":"https://pubmed.ncbi.nlm.nih.gov/28481040","citation_count":8,"is_preprint":false},{"pmid":"27324188","id":"PMC_27324188","title":"Cobalamin C defect-hemolytic uremic syndrome caused by new mutation in MMACHC.","date":"2016","source":"Pediatrics international : official journal of the Japan Pediatric Society","url":"https://pubmed.ncbi.nlm.nih.gov/27324188","citation_count":8,"is_preprint":false},{"pmid":"33074687","id":"PMC_33074687","title":"Chlorocob(II)alamin Formation Which Enhances the Thiol Oxidase Activity of the B12-Trafficking Protein CblC.","date":"2020","source":"Inorganic chemistry","url":"https://pubmed.ncbi.nlm.nih.gov/33074687","citation_count":8,"is_preprint":false},{"pmid":"38070096","id":"PMC_38070096","title":"Variable phenotypes and outcomes associated with the MMACHC c.482G > A mutation: follow-up in a large CblC disease cohort.","date":"2023","source":"World journal of pediatrics : WJP","url":"https://pubmed.ncbi.nlm.nih.gov/38070096","citation_count":8,"is_preprint":false},{"pmid":"34704411","id":"PMC_34704411","title":"Clinical features and outcomes of patients with cblC type methylmalonic acidemia carrying gene c.609G>A mutation.","date":"2021","source":"Zhejiang da xue xue bao. Yi xue ban = Journal of Zhejiang University. Medical sciences","url":"https://pubmed.ncbi.nlm.nih.gov/34704411","citation_count":8,"is_preprint":false},{"pmid":"33982424","id":"PMC_33982424","title":"Epimutation of MMACHC compound to a genetic mutation in cblC cases.","date":"2021","source":"Molecular genetics & genomic medicine","url":"https://pubmed.ncbi.nlm.nih.gov/33982424","citation_count":7,"is_preprint":false},{"pmid":"35069678","id":"PMC_35069678","title":"Noninvasive Prenatal Testing of Methylmalonic Acidemia cblC Type Using the cSMART Assay for MMACHC Gene Mutations.","date":"2022","source":"Frontiers in genetics","url":"https://pubmed.ncbi.nlm.nih.gov/35069678","citation_count":7,"is_preprint":false},{"pmid":"36704130","id":"PMC_36704130","title":"Prominent renal complications associated with MMACHC pathogenic variant c.80A > G in Chinese children with cobalamin C deficiency.","date":"2023","source":"Frontiers in pediatrics","url":"https://pubmed.ncbi.nlm.nih.gov/36704130","citation_count":7,"is_preprint":false},{"pmid":"36376887","id":"PMC_36376887","title":"Efficacy and pharmacokinetics of betaine in CBS and cblC deficiencies: a cross-over randomized controlled trial.","date":"2022","source":"Orphanet journal of rare diseases","url":"https://pubmed.ncbi.nlm.nih.gov/36376887","citation_count":6,"is_preprint":false},{"pmid":"35589192","id":"PMC_35589192","title":"The human B12 trafficking chaperones: CblA, ATR, CblC and CblD.","date":"2022","source":"Methods in enzymology","url":"https://pubmed.ncbi.nlm.nih.gov/35589192","citation_count":6,"is_preprint":false},{"pmid":"35618206","id":"PMC_35618206","title":"Investigation on a MMACHC mutant from cblC disease: The c.394C>T variant.","date":"2022","source":"Biochimica et biophysica acta. Proteins and proteomics","url":"https://pubmed.ncbi.nlm.nih.gov/35618206","citation_count":6,"is_preprint":false},{"pmid":"34147638","id":"PMC_34147638","title":"Absence of MMACHC in peripheral retinal cells does not lead to an ocular phenotype in mice.","date":"2021","source":"Biochimica et biophysica acta. Molecular basis of disease","url":"https://pubmed.ncbi.nlm.nih.gov/34147638","citation_count":6,"is_preprint":false},{"pmid":"37167860","id":"PMC_37167860","title":"Abnormal chondrocyte development in a zebrafish model of cblC syndrome restored by an MMACHC cobalamin binding mutant.","date":"2023","source":"Differentiation; research in biological diversity","url":"https://pubmed.ncbi.nlm.nih.gov/37167860","citation_count":6,"is_preprint":false},{"pmid":"19414407","id":"PMC_19414407","title":"Abnormal mammary gland development in MMTV-CBLC transgenic mouse.","date":"2009","source":"In vivo (Athens, Greece)","url":"https://pubmed.ncbi.nlm.nih.gov/19414407","citation_count":6,"is_preprint":false},{"pmid":"26393512","id":"PMC_26393512","title":"The Ubiquitin Ligase CBLC Maintains the Network Organization of the Golgi Apparatus.","date":"2015","source":"PloS one","url":"https://pubmed.ncbi.nlm.nih.gov/26393512","citation_count":6,"is_preprint":false},{"pmid":"1676355","id":"PMC_1676355","title":"Metabolic cooperation among cell lines from patients with inborn errors of vitamin B12 metabolism: differential response of cblC and cblD.","date":"1991","source":"Clinical and investigative medicine. Medecine clinique et experimentale","url":"https://pubmed.ncbi.nlm.nih.gov/1676355","citation_count":5,"is_preprint":false},{"pmid":"36043996","id":"PMC_36043996","title":"CBLC inhibits the proliferation and metastasis of breast cancer cells via ubiquitination and degradation of CTTN.","date":"2022","source":"Journal of receptor and signal transduction research","url":"https://pubmed.ncbi.nlm.nih.gov/36043996","citation_count":5,"is_preprint":false},{"pmid":"32068834","id":"PMC_32068834","title":"Analysis of fibroblasts from patients with cblC and cblG genetic defects of cobalamin metabolism reveals global dysregulation of alternative splicing.","date":"2020","source":"Human molecular genetics","url":"https://pubmed.ncbi.nlm.nih.gov/32068834","citation_count":5,"is_preprint":false},{"pmid":"37604084","id":"PMC_37604084","title":"Would, early, versus late hydroxocobalamin dose intensification treatment, prevent cognitive decline, macular degeneration and ocular disease, in 5 patients with early-onset cblC deficiency?","date":"2023","source":"Molecular genetics and metabolism","url":"https://pubmed.ncbi.nlm.nih.gov/37604084","citation_count":5,"is_preprint":false},{"pmid":"26464686","id":"PMC_26464686","title":"Genetic analysis of four cases of methylmalonic aciduria and homocystinuria, cblC type#.","date":"2015","source":"International journal of clinical and experimental pathology","url":"https://pubmed.ncbi.nlm.nih.gov/26464686","citation_count":5,"is_preprint":false},{"pmid":"11162497","id":"PMC_11162497","title":"Characterization of the mouse Cblc/Cbl3 gene.","date":"2001","source":"Biochemical and biophysical research communications","url":"https://pubmed.ncbi.nlm.nih.gov/11162497","citation_count":5,"is_preprint":false},{"pmid":"38355526","id":"PMC_38355526","title":"Clinical and electroencephalogram characteristics of methylmalonic acidemia with MMACHC and MUT gene mutations.","date":"2024","source":"BMC pediatrics","url":"https://pubmed.ncbi.nlm.nih.gov/38355526","citation_count":5,"is_preprint":false},{"pmid":"32058304","id":"PMC_32058304","title":"Generation of a Human iPSC line (SDQLCHi021-A) from a patient with methylmalonic acidemia cblC type carrying compound heterozygous mutations in MMAHC gene.","date":"2020","source":"Stem cell research","url":"https://pubmed.ncbi.nlm.nih.gov/32058304","citation_count":5,"is_preprint":false},{"pmid":"35636712","id":"PMC_35636712","title":"HIF1 and DROSHA are involved in MMACHC repression in hypoxia.","date":"2022","source":"Biochimica et biophysica acta. General subjects","url":"https://pubmed.ncbi.nlm.nih.gov/35636712","citation_count":4,"is_preprint":false}],"cost":{"stage1":{"model":"claude-sonnet-4-6","input_tokens":52814,"output_tokens":6996,"usd":0.131691},"stage2":{"model":"claude-opus-4-6","input_tokens":10695,"output_tokens":3332,"usd":0.205162},"total_usd":0.336853,"stage1_batch_id":"msgbatch_01Mgbec4vM6c9vXht7JVJzss","stage2_batch_id":"msgbatch_01JkuuH5RB2BdJNsgnhjbC6s","note":"batch pricing = 50% of standard"},"stage1_raw":"```json\n{\n  \"discoveries\": [\n    {\n      \"year\": 2005,\n      \"finding\": \"MMACHC was identified as the gene responsible for cblC-type methylmalonic aciduria and homocystinuria; transduction of wild-type MMACHC into immortalized cblC fibroblast cell lines corrected the cellular phenotype (impaired synthesis of adenosylcobalamin and methylcobalamin), establishing its essential role in intracellular cobalamin processing.\",\n      \"method\": \"Homozygosity mapping, haplotype analysis, mutation identification in 204 patients, retroviral transduction complementation of cblC fibroblasts\",\n      \"journal\": \"Nature genetics\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 2 — functional complementation in patient cell lines, replicated across large cohort; foundational discovery paper\",\n      \"pmids\": [\"16311595\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2009,\n      \"finding\": \"The MMACHC (cblC) protein catalyzes in vitro and in vivo decyanation of cyanocobalamin (CNCbl) and dealkylation of naturally occurring alkylcobalamins (MeCbl, AdoCbl, and straight-chain alkylcobalamins C2–C6); cblC mutant fibroblasts failed to convert propylcobalamin to AdoCbl or MeCbl, confirming MMACHC is responsible for early processing of both CNCbl and alkylcobalamins in mammalian cells.\",\n      \"method\": \"Radioisotopic (57Co) substrate conversion assays in cultured endothelial cells and patient vs. control skin fibroblasts; in vitro enzymatic assays\",\n      \"journal\": \"Molecular genetics and metabolism\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 1 — in vitro and cell-based enzymatic assays with patient-derived loss-of-function controls\",\n      \"pmids\": [\"19447654\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2009,\n      \"finding\": \"Wild-type MMACHC binds both OHCbl and CNCbl with similar micromolar affinity (Kd ~5.7 µM) and binds CNCbl in the 'base-off' configuration; NADPH and FAD are required for reductive decyanation of CNCbl to cob(II)alamin. The G147D mutation abolishes binding of both CNCbl and OHCbl (explaining vitamin unresponsiveness), while R161Q retains OHCbl binding but is impaired in CNCbl binding and decyanation (explaining selective OHCbl responsiveness).\",\n      \"method\": \"Recombinant protein binding assays, spectroscopic analysis of base-off CNCbl binding, in vitro decyanation assays with NADPH/FAD, patient mutation analysis\",\n      \"journal\": \"Molecular genetics and metabolism\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 1 — reconstituted in vitro enzymatic and binding assays with mutagenesis\",\n      \"pmids\": [\"19700356\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2012,\n      \"finding\": \"Crystal structure of human MMACHC bound to adenosyl-Cbl revealed a nitroreductase scaffold that binds AdoCbl in a 'base-off, five-coordinate' configuration. An arginine-rich pocket (including Arg161) is required for glutathione (GSH) binding and dealkylation activity. MMACHC dimerizes via reciprocal exchange of a conserved 'PNRRP' loop that caps the upper axial ligand in trans and is required for proper dealkylation. Mutation of conserved arginines (including disease-associated Arg161Gln) disrupts GSH binding and dealkylation.\",\n      \"method\": \"X-ray crystallography, solution studies (dimerization triggered by AdoCbl or FMN binding), site-directed mutagenesis, dealkylation activity assays\",\n      \"journal\": \"Biochemistry\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 1 — crystal structure with functional mutagenesis validation and solution studies; multiple orthogonal methods in single study\",\n      \"pmids\": [\"22642810\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2010,\n      \"finding\": \"MMACHC protein is thermolabile in its apo form (Tm ~39°C); binding of cobalamins substantially stabilizes the protein (AdoCbl provides the greatest stabilization, ΔTm ~16°C). The late-onset disease mutant R161Q is less thermostable and is less stabilized by cobalamins compared to wild-type, suggesting protein instability as a disease mechanism.\",\n      \"method\": \"Differential scanning fluorimetry, isothermal denaturation of recombinant wild-type and R161Q MMACHC proteins with various cobalamin ligands\",\n      \"journal\": \"Molecular genetics and metabolism\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 1 — rigorous in vitro biophysical characterization of purified recombinant wild-type and mutant proteins with multiple ligands\",\n      \"pmids\": [\"20219402\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2010,\n      \"finding\": \"MMACHC and MMADHC interact directly: MMADHC was confirmed as a binding partner for MMACHC both in vitro (surface plasmon resonance) and in vivo (bacterial two-hybrid). MMACHC binds MeCbl and AdoCbl with higher affinity (Kd ~1.4–1.7 µM) than CNCbl and OHCbl (Kd ~6.4–9.8 µM).\",\n      \"method\": \"Surface plasmon resonance, bacterial two-hybrid, dynamic light scattering, solution-phase intrinsic fluorescence, phage display mapping of binding sites\",\n      \"journal\": \"Molecular genetics and metabolism\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 2 — multiple orthogonal biophysical methods confirming protein-protein interaction and cobalamin binding affinities\",\n      \"pmids\": [\"21071249\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2012,\n      \"finding\": \"Subcellular fractionation and immunofluorescence established that MMACHC is exclusively cytoplasmic, while MMADHC is both mitochondrial and cytoplasmic, consistent with MMACHC functioning in cytoplasmic cobalamin processing and MMADHC acting as a branch point for cofactor delivery to cytoplasm and mitochondria. Retroviral GFP-tagged MMACHC rescued all biochemical defects in cblC fibroblasts.\",\n      \"method\": \"Immunofluorescence, subcellular fractionation, retroviral complementation of cblC and cblD fibroblasts\",\n      \"journal\": \"Molecular genetics and metabolism\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 2 — direct localization by two independent methods with functional complementation\",\n      \"pmids\": [\"23270877\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2012,\n      \"finding\": \"MMADHC does not bind cobalamin but interacts with MMACHC through its structured C-terminal domain; MMACHC self-association is weaker than its interaction with either MMADHC isoform. Phage display predicted four MMACHC-binding sites on MMADHC, two overlapping with MMACHC self-association sites.\",\n      \"method\": \"Clear-native PAGE, dynamic light scattering, circular dichroism, phage display, surface plasmon resonance\",\n      \"journal\": \"Molecular genetics and metabolism\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 1–2 — multiple biophysical methods characterizing interaction with mutagenesis-informed mapping\",\n      \"pmids\": [\"22832074\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2013,\n      \"finding\": \"CblC (MMACHC) and CblD (MMADHC) form a stable complex particularly under conditions that permit dealkylation of alkylcobalamin by CblC or in the presence of the dealkylated product hydroxocobalamin; CblD functions downstream of CblC and controls cofactor partitioning between cytoplasmic MeCbl and mitochondrial AdoCbl pathways. The CblD N-terminal 115 residues are not required for CblC interaction.\",\n      \"method\": \"Co-immunoprecipitation of complex from fibroblast cell lines, pulldown with CblD variants, limited proteolysis, dealkylation assays\",\n      \"journal\": \"Biochimie\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 2 — reciprocal co-IP with functional context, confirmed with multiple CblD variants\",\n      \"pmids\": [\"23415655\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2013,\n      \"finding\": \"Methionine synthase (MS) interacts with MMACHC; this interaction is decreased by cblC disease mutations R161Q and R206W in MMACHC as shown by co-immunoprecipitation and proximity ligation assay. 3D modelling showed MS provides a loop making contacts with MMACHC residues R161 and R206.\",\n      \"method\": \"Co-immunoprecipitation, proximity ligation assay (DuoLink), 3D modelling and docking, siRNA knockdown of MS in HEK cells\",\n      \"journal\": \"Human molecular genetics\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 2 — multiple orthogonal methods (co-IP, PLA, computational modeling) across multiple cell lines\",\n      \"pmids\": [\"23825108\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2015,\n      \"finding\": \"Crystal structure of the MMADHC C-terminal region revealed a modified nitroreductase fold with surprising structural homology to MMACHC despite low sequence conservation. MMACHC processes Cbl prior to interaction with MMADHC; patient mutations on both proteins interfere with complex formation. SAXS revealed a 1:1 MMACHC–MMADHC heterodimer where the interaction region overlaps with the MMACHC–Cbl binding site.\",\n      \"method\": \"X-ray crystallography (2.2 Å), small angle X-ray scattering (SAXS), mutagenesis of disease-associated residues, interaction mapping\",\n      \"journal\": \"The Journal of biological chemistry\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 1 — crystal structure plus SAXS plus disease mutation functional validation; multiple orthogonal methods\",\n      \"pmids\": [\"26483544\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2015,\n      \"finding\": \"Pathogenic missense mutations R161Q (late-onset) and R161G (early-onset) at the same MMACHC residue selectively decrease dealkylation but not decyanation activity, impair glutathione binding, and reduce protein stability. Both mutants exhibit increased futile thiol oxidase cycling (GSH oxidation to GSSG) in the presence of physiological glutathione concentrations, explaining the increased oxidative stress in cblC patients.\",\n      \"method\": \"In vitro enzymatic assays for dealkylation and decyanation, glutathione binding assays, thiol oxidase activity assays, protein stability measurements with purified recombinant proteins\",\n      \"journal\": \"The Journal of biological chemistry\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 1 — reconstituted in vitro assays with mutagenesis; mechanistic explanation for genotype-phenotype difference\",\n      \"pmids\": [\"25809485\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2016,\n      \"finding\": \"MS, MSR, MMACHC, and MMADHC form a multiprotein complex in the cytoplasm for intracellular cobalamin processing; novel interactions of MSR with MMACHC and with MMADHC, and MS with MMADHC were identified. Absence of MS or MMACHC expression disrupts interactions among other complex members.\",\n      \"method\": \"Co-immunoprecipitation, DuoLink proximity ligation assays in patient fibroblasts with cblG, cblE, and cblC defects, and siRNA-transfected HepG2 cells\",\n      \"journal\": \"Biochimica et biophysica acta. Molecular basis of disease\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 2 — reciprocal co-IP and proximity ligation assay across multiple genetic backgrounds\",\n      \"pmids\": [\"27771510\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2017,\n      \"finding\": \"The antivitamin B12 compound F2PhEtyCbl binds human CblC (MMACHC) with high affinity (KD = 130 nM) in the presence of GSH, resists dealkylation by CblC, and stabilizes the ternary CblC–F2PhEtyCbl–GSH complex. The crystal structure of this inactive ternary complex revealed binding interactions between the antivitamin and CblC and the organization of GSH and base-off cobalamin in the active site.\",\n      \"method\": \"Crystal structure of ternary CblC–antivitamin–GSH complex, KD measurement, enzymatic stability assay\",\n      \"journal\": \"Angewandte Chemie (International ed. in English)\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 1 — crystal structure of active site complex with biochemical validation\",\n      \"pmids\": [\"28544088\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2017,\n      \"finding\": \"Novel coordination chemistry of CblC-bound cobalamin supports thiol oxidase activity via a glutathionyl-cobalamin intermediate; deglutathionylation by a second GSH molecule yields GSSG. The R161G and R161Q disease mutations in human CblC unmask latent thiol oxidase activity present in wild-type CblC (C. elegans CblC as model). Crystal structure of C. elegans CblC showed architectural differences at the α- and β-faces of cobalamin that promote or suppress this activity.\",\n      \"method\": \"In vitro thiol oxidase activity assays, crystal structure of C. elegans CblC, UV-vis and EPR spectroscopy, mutant CblC characterization\",\n      \"journal\": \"The Journal of biological chemistry\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 1 — crystal structure plus mechanistic enzymatic assays with human disease mutations\",\n      \"pmids\": [\"28442570\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2018,\n      \"finding\": \"MMACHC is subject to epigenetic silencing: mutations in the adjacent PRDX1 gene force antisense transcription across the MMACHC locus, generating H3K36me3 marks and promoter hypermethylation (epimutation) that silences MMACHC. 5-azacytidine treatment restored MMACHC expression in fibroblasts. The epimutation was detected in blood, fibroblasts, and sperm and was transmitted across three generations.\",\n      \"method\": \"Bisulfite sequencing, methylation-specific PCR, 5-azacytidine rescue of expression, PRDX1 silencing experiments, ChIP for H3K36me3\",\n      \"journal\": \"Nature communications\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 2 — multiple orthogonal epigenetic methods, functional rescue, multigenerational evidence\",\n      \"pmids\": [\"29302025\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2009,\n      \"finding\": \"Epigenetic inactivation (promoter CpG island hypermethylation) of the MMACHC gene causes methionine dependence and a cblC-like cellular phenotype in the MeWo-LC1 melanoma cell line; retroviral infection with wild-type MMACHC corrected the cobalamin metabolism defect and restored growth on homocysteine, establishing that MMACHC loss drives this phenotype.\",\n      \"method\": \"Complementation analysis with cblC fibroblasts, bisulfite sequencing/methylation analysis of CpG island, quantitative PCR, retroviral MMACHC transduction\",\n      \"journal\": \"Molecular genetics and metabolism\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 2 — functional complementation plus epigenetic mechanism; multiple orthogonal methods\",\n      \"pmids\": [\"19200761\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2014,\n      \"finding\": \"Loss of HCFC1 ortholog hcfc1b in zebrafish causes craniofacial development defects through reduced mmachc expression; craniofacial abnormalities were rescued by expression of human MMACHC, placing MMACHC downstream of HCFC1/HCFC1B in a pathway required for craniofacial development.\",\n      \"method\": \"Zebrafish loss-of-function (hcfc1b morpholino), rescue with human MMACHC expression, neural crest cell differentiation/proliferation assays, human HCFC1 mutation analysis\",\n      \"journal\": \"Developmental biology\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 2 — genetic epistasis in zebrafish with rescue experiment; establishes pathway position\",\n      \"pmids\": [\"25281006\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2014,\n      \"finding\": \"Homozygous gene-trap inactivation of Mmachc in mice is lethal before embryonic day 3.5; heterozygous mice have 50% reduced MMACHC protein and significantly elevated homocysteine and methylmalonic acid, establishing that Mmachc is essential for pre-implantation embryogenesis and demonstrating dose-sensitivity in vivo.\",\n      \"method\": \"Gene-trap mouse model, Western blot for MMACHC protein quantification, metabolite measurements (plasma homocysteine and MMA), blastocyst outgrowth assay\",\n      \"journal\": \"Molecular genetics and metabolism\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 2 — clean KO with defined cellular and metabolic phenotype\",\n      \"pmids\": [\"24889031\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2020,\n      \"finding\": \"CblC (MMACHC) catalyzes GSH-dependent denitration of nitrocobalamin (NO2Cbl) forming 5-coordinate cob(II)alamin; this cob(II)alamin can be oxidized or enter a futile thiol oxidase cycle. CblC also exhibits nitrite reductase activity (converting cob(I)alamin and nitrite to NOCbl). The R161G disease variant stabilizes cob(II)alamin and promotes futile cycling. Denitration activity of CblC supported cell proliferation in the presence of NO2Cbl.\",\n      \"method\": \"In vitro enzymatic assays with purified recombinant CblC, UV-vis spectroscopy, cell proliferation assays in presence of NO2Cbl\",\n      \"journal\": \"The Journal of biological chemistry\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 1 — reconstituted in vitro assays with mutagenesis and cell-based functional validation\",\n      \"pmids\": [\"32457044\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2020,\n      \"finding\": \"Loss of mmachc function in zebrafish (CRISPR/Cas9 knockout) results in methylmalonic acidemia, severe growth retardation, and lethality in early juvenile life, recapitulating human cblC disease. Retinopathy and thin optic nerves were observed; metabolic and morphological parameters improved with hydroxocobalamin, methylcobalamin, methionine, and betaine supplementation.\",\n      \"method\": \"CRISPR/Cas9 genome editing, metabolite measurements, morphological and retinal phenotyping, fluorescent reporter lines, pharmacological rescue\",\n      \"journal\": \"Human molecular genetics\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 2 — clean KO with defined metabolic and ocular phenotypes, pharmacological rescue\",\n      \"pmids\": [\"32186706\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2013,\n      \"finding\": \"The deletion mutation MMACHC-Gln131del (c.392_394del) results in a folded but perturbed protein with reduced enzymatic activity; structural analysis showed Gln131 makes hydrogen bonds to the tail of cobalamin, and its deletion reduces cobalamin binding and enzyme activity as shown by spectroscopic assays on recombinant protein and patient fibroblast studies.\",\n      \"method\": \"Recombinant protein spectroscopic activity assays, circular dichroism spectroscopy, fibroblast complementation studies\",\n      \"journal\": \"JIMD reports\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 1 — in vitro structural and enzymatic characterization; single study\",\n      \"pmids\": [\"23580368\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2022,\n      \"finding\": \"Biophysical analysis of the disease-associated MMACHC-R132X truncation mutant (from c.394C>T) showed it retains secondary structure and remains compact in solution, partly preserving cobalamin binding affinity, consistent with residual function associated with late-onset disease phenotype.\",\n      \"method\": \"Circular dichroism, fluorescence spectroscopy, small angle X-ray scattering (SAXS), molecular dynamics\",\n      \"journal\": \"Biochimica et biophysica acta. Proteins and proteomics\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 1 — multiple biophysical methods; single study, no functional enzymatic assay\",\n      \"pmids\": [\"35618206\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2022,\n      \"finding\": \"MMACHC transcription is repressed by hypoxia; this repression is partially mediated by HIF1A and the microRNA biogenesis factor DROSHA (whose knockdowns additively released repression), but not through the known HCFC1/THAP11/ZNF143 transcription factor complex.\",\n      \"method\": \"Hypoxia exposure of multiple cell lines and mouse tissues, RT-qPCR, RNA interference against HIF1A, HIF2A, REST, DROSHA\",\n      \"journal\": \"Biochimica et biophysica acta. General subjects\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 2 — RNAi in multiple cell lines; single lab, mechanism partially defined\",\n      \"pmids\": [\"35636712\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2020,\n      \"finding\": \"Thiolatocobalamins (cysteaminylcobalamin and 2-mercaptopropionylglycinocobalamin) bind to human CblC and undergo GSH-dependent dethiolation; they can repair the loss of dealkylation activity of pathogenic CblC variants R161G and R161Q, as the spontaneous dethiolation rate is orders of magnitude faster than alkylcobalamin dealkylation.\",\n      \"method\": \"In vitro binding and dethiolation kinetics with purified recombinant wild-type and mutant human CblC, UV-vis spectroscopy\",\n      \"journal\": \"Biochimie\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 1 — in vitro reconstituted assays; single study, no cell-based validation\",\n      \"pmids\": [\"33190793\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2011,\n      \"finding\": \"cblC patient fibroblasts show increased export of homocysteine and methylmalonic acid, decreased total intracellular folates, and broad proteome changes (cytoskeletal, neurological, and signaling proteins) compared to controls; hydroxocobalamin supplementation did not restore the proteome to control patterns.\",\n      \"method\": \"2D-DIGE and LC/ESI/MS proteomics of control vs. cblC fibroblasts, metabolite measurements\",\n      \"journal\": \"Molecular genetics and metabolism\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 2 — quantitative proteomics with defined loss-of-function; single lab\",\n      \"pmids\": [\"21497120\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2021,\n      \"finding\": \"Peripheral retinal neurons do not require intrinsic MMACHC expression for survival and function; conditional deletion of Mmachc in peripheral retinal cells in mice led to accumulation of MMA and folate-cycle intermediates but did not cause retinal morphological or functional defects, suggesting the retinal phenotype in cblC patients is not due to local MMACHC deficiency.\",\n      \"method\": \"Conditional Mmachc knockout mouse (Cre-lox), metabolite quantification in retina, fundus imaging, electroretinography, retinal histology\",\n      \"journal\": \"Biochimica et biophysica acta. Molecular basis of disease\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 2 — clean conditional KO with multi-modal retinal phenotyping; single study\",\n      \"pmids\": [\"34147638\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2023,\n      \"finding\": \"In a zebrafish cblC model (mmachc hg13 mutant), homozygous mutation causes abnormal chondrocyte nuclear organization and increased neighboring cell contacts; both phenotypes were fully rescued by wild-type MMACHC and by a cobalamin-binding–deficient MMACHC variant, indicating these craniofacial defects are independent of cobalamin binding.\",\n      \"method\": \"Zebrafish genetic model, rescue experiments with wild-type and cobalamin-binding mutant MMACHC, chondrocyte morphological analysis, neural crest marker localization\",\n      \"journal\": \"Differentiation; research in biological diversity\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 2 — genetic rescue with separation-of-function mutant; single study\",\n      \"pmids\": [\"37167860\"],\n      \"is_preprint\": false\n    }\n  ],\n  \"current_model\": \"MMACHC (CblC) is a cytoplasmic multifunctional processing chaperone that removes the upper axial ligand from all dietary and supplemental cobalamin derivatives—catalyzing FMN/NADPH-dependent reductive decyanation of cyanocobalamin and GSH-dependent dealkylation of alkylcobalamins—via a nitroreductase scaffold that binds cobalamin in a 'base-off' configuration with an arginine-rich pocket coordinating GSH; it functions as a domain-swapped dimer and acts in a multiprotein complex with MMADHC, methionine synthase, and methionine synthase reductase to generate cob(II)alamin for downstream delivery to adenosylcobalamin and methylcobalamin synthesis pathways, with disease mutations either abolishing cobalamin binding, impairing dealkylation and destabilizing the protein, or promoting futile thiol oxidase cycling that increases cellular oxidative stress.\"\n}\n```","stage2_raw":"```json\n{\n  \"mechanistic_narrative\": \"MMACHC is a cytoplasmic cobalamin (vitamin B12) processing enzyme that catalyzes removal of the upper axial ligand from all dietary cobalamin derivatives, serving as the essential first step in intracellular generation of the cofactors adenosylcobalamin and methylcobalamin [PMID:16311595, PMID:19447654]. It adopts a nitroreductase fold that binds cobalamin in a base-off configuration as a domain-swapped dimer, performing FMN/NADPH-dependent reductive decyanation of cyanocobalamin and GSH-dependent dealkylation of alkylcobalamins through an arginine-rich active site that coordinates glutathione [PMID:22642810, PMID:19700356]. MMACHC operates within a cytoplasmic multiprotein complex with MMADHC, methionine synthase, and methionine synthase reductase, where MMADHC acts downstream to partition processed cob(II)alamin between cytoplasmic and mitochondrial cofactor synthesis pathways [PMID:27771510, PMID:23415655]. Biallelic loss-of-function mutations in MMACHC cause cblC-type combined methylmalonic aciduria and homocystinuria, with disease-associated mutations at Arg161 selectively impairing dealkylation and GSH binding while unmasking a futile thiol oxidase activity that promotes oxidative stress [PMID:16311595, PMID:25809485, PMID:28442570].\",\n  \"teleology\": [\n    {\n      \"year\": 2005,\n      \"claim\": \"Identification of MMACHC as the cblC disease gene resolved a decades-long search for the genetic basis of the most common inborn error of intracellular cobalamin metabolism, establishing that this single gene is required for synthesis of both adenosylcobalamin and methylcobalamin.\",\n      \"evidence\": \"Homozygosity mapping and mutation identification in 204 patients, with retroviral complementation of cblC fibroblasts\",\n      \"pmids\": [\"16311595\"],\n      \"confidence\": \"High\",\n      \"gaps\": [\"Enzymatic mechanism unknown at this stage\", \"Subcellular localization not determined\", \"Protein partners not identified\"]\n    },\n    {\n      \"year\": 2009,\n      \"claim\": \"Demonstration that MMACHC catalyzes both decyanation of cyanocobalamin (NADPH/FAD-dependent) and dealkylation of naturally occurring alkylcobalamins, with base-off CNCbl binding, defined the dual enzymatic activities and cofactor requirements of the protein.\",\n      \"evidence\": \"Radioisotopic substrate conversion in patient vs. control fibroblasts, in vitro enzymatic and binding assays with recombinant protein and cobalamin ligands\",\n      \"pmids\": [\"19447654\", \"19700356\"],\n      \"confidence\": \"High\",\n      \"gaps\": [\"Three-dimensional structure not yet available\", \"Mechanism of GSH involvement in dealkylation unknown\", \"Protein interaction network not characterized\"]\n    },\n    {\n      \"year\": 2010,\n      \"claim\": \"Biophysical characterization revealed that apo-MMACHC is thermolabile and stabilized by cobalamin binding, while identification of MMADHC as a direct physical partner established the first component of a cobalamin processing relay.\",\n      \"evidence\": \"Differential scanning fluorimetry of wild-type and R161Q proteins with cobalamin ligands; surface plasmon resonance and bacterial two-hybrid for MMACHC–MMADHC interaction\",\n      \"pmids\": [\"20219402\", \"21071249\"],\n      \"confidence\": \"High\",\n      \"gaps\": [\"Structural basis of MMACHC–MMADHC interaction unknown\", \"Whether MMACHC functions as monomer or oligomer unclear\", \"Interaction with methionine synthase not yet tested\"]\n    },\n    {\n      \"year\": 2012,\n      \"claim\": \"The crystal structure of MMACHC bound to AdoCbl revealed a nitroreductase scaffold with a domain-swapped dimer architecture and an arginine-rich GSH-binding pocket, providing the structural basis for dealkylation catalysis and explaining why Arg161 mutations cause disease; concurrent localization studies confirmed exclusive cytoplasmic residence.\",\n      \"evidence\": \"X-ray crystallography with site-directed mutagenesis and dealkylation assays; immunofluorescence and subcellular fractionation with retroviral complementation\",\n      \"pmids\": [\"22642810\", \"23270877\", \"22832074\"],\n      \"confidence\": \"High\",\n      \"gaps\": [\"Structural basis of the MMACHC–MMADHC heterodimer not resolved\", \"Mechanism of cobalamin handoff to downstream partners unknown\", \"Decyanation reaction mechanism at atomic level not defined\"]\n    },\n    {\n      \"year\": 2013,\n      \"claim\": \"Discovery that methionine synthase is a direct MMACHC-binding partner, with disease mutations R161Q and R206W disrupting this interaction, expanded the processing model from a two-protein relay to a multi-component complex enabling direct cofactor delivery.\",\n      \"evidence\": \"Co-immunoprecipitation and proximity ligation assay in multiple cell lines with 3D docking models\",\n      \"pmids\": [\"23825108\", \"23415655\"],\n      \"confidence\": \"High\",\n      \"gaps\": [\"Methionine synthase reductase (MSR) role in the complex not yet defined\", \"Stoichiometry and assembly order of the full complex unknown\", \"Whether complex formation is cobalamin-dependent in cells not established\"]\n    },\n    {\n      \"year\": 2014,\n      \"claim\": \"Mouse knockout revealed that Mmachc is essential for pre-implantation embryogenesis with haploinsufficiency causing metabolic perturbations, while zebrafish studies placed MMACHC downstream of HCFC1 in craniofacial development, defining in vivo requirements beyond cobalamin metabolism.\",\n      \"evidence\": \"Gene-trap mouse model with metabolite measurements; zebrafish hcfc1b morpholino with human MMACHC rescue\",\n      \"pmids\": [\"24889031\", \"25281006\"],\n      \"confidence\": \"High\",\n      \"gaps\": [\"Mechanism of MMACHC's role in craniofacial development beyond cobalamin processing unclear\", \"Conditional tissue-specific requirements not systematically mapped\", \"Whether craniofacial phenotype is cobalamin-dependent or independent not resolved\"]\n    },\n    {\n      \"year\": 2015,\n      \"claim\": \"Structural resolution of the MMACHC–MMADHC heterodimer by SAXS, together with the finding that Arg161 mutations selectively impair dealkylation while unmasking futile thiol oxidase cycling, provided a mechanistic framework linking genotype to disease severity and oxidative stress.\",\n      \"evidence\": \"SAXS of 1:1 heterodimer and crystal structure of MMADHC; in vitro dealkylation, decyanation, GSH binding, and thiol oxidase assays with R161Q/R161G mutants\",\n      \"pmids\": [\"26483544\", \"25809485\"],\n      \"confidence\": \"High\",\n      \"gaps\": [\"Atomic-resolution structure of intact MMACHC–MMADHC complex not available\", \"In vivo contribution of thiol oxidase activity to patient pathology not quantified\", \"Mechanism controlling whether cob(II)alamin enters productive vs. futile cycle not defined\"]\n    },\n    {\n      \"year\": 2016,\n      \"claim\": \"Identification of MSR–MMACHC and MSR–MMADHC interactions completed the picture of a four-protein cytoplasmic cobalamin processing complex (MMACHC–MMADHC–MS–MSR), where loss of any core member disrupts complex assembly.\",\n      \"evidence\": \"Co-immunoprecipitation and proximity ligation assays in patient fibroblasts with cblC, cblG, and cblE defects, and siRNA-transfected HepG2 cells\",\n      \"pmids\": [\"27771510\"],\n      \"confidence\": \"High\",\n      \"gaps\": [\"Whether complex is constitutive or cobalamin-regulated in vivo unknown\", \"No reconstitution of full four-protein complex in vitro\", \"Kinetic pathway of cobalamin transfer through complex not defined\"]\n    },\n    {\n      \"year\": 2017,\n      \"claim\": \"Crystal structures of MMACHC with an antivitamin B12 analogue and characterization of C. elegans CblC defined the active-site architecture for GSH-dependent catalysis and established that thiol oxidase activity proceeds through a glutathionyl-cobalamin intermediate.\",\n      \"evidence\": \"Crystal structures of human CblC–antivitamin–GSH ternary complex and C. elegans CblC; in vitro thiol oxidase assays with EPR spectroscopy\",\n      \"pmids\": [\"28544088\", \"28442570\"],\n      \"confidence\": \"High\",\n      \"gaps\": [\"No time-resolved structural data capturing catalytic intermediates during dealkylation\", \"Physiological regulation of thiol oxidase activity not characterized\", \"No structural data for decyanation reaction mechanism\"]\n    },\n    {\n      \"year\": 2018,\n      \"claim\": \"Discovery that MMACHC can be epigenetically silenced by antisense transcription-induced promoter methylation originating from the adjacent PRDX1 locus, with transgenerational inheritance, established a non-Mendelian mechanism for cblC disease.\",\n      \"evidence\": \"Bisulfite sequencing, ChIP for H3K36me3, 5-azacytidine rescue of expression, multigenerational pedigree analysis\",\n      \"pmids\": [\"29302025\"],\n      \"confidence\": \"High\",\n      \"gaps\": [\"Frequency of epimutation among cblC patients not systematically determined\", \"Mechanism of transgenerational epigenetic escape from reprogramming unknown\", \"Whether other loci can similarly silence MMACHC not explored\"]\n    },\n    {\n      \"year\": 2020,\n      \"claim\": \"Extension of MMACHC's substrate repertoire to nitrocobalamin and thiolatocobalamins broadened the catalytic scope and demonstrated that thiolatocobalamins can bypass dealkylation defects in R161 mutants, suggesting therapeutic avenues.\",\n      \"evidence\": \"In vitro denitration and dethiolation assays with recombinant wild-type and mutant CblC; cell proliferation assays with NO2Cbl\",\n      \"pmids\": [\"32457044\", \"33190793\"],\n      \"confidence\": \"High\",\n      \"gaps\": [\"No cell-based validation of thiolatocobalamin rescue of disease mutations\", \"In vivo relevance of nitrocobalamin processing not established\", \"Pharmacokinetics of thiolatocobalamins not evaluated\"]\n    },\n    {\n      \"year\": 2023,\n      \"claim\": \"Zebrafish rescue experiments with a cobalamin-binding-deficient MMACHC variant demonstrated that certain craniofacial developmental functions of MMACHC are independent of its cobalamin processing activity, revealing a potential non-canonical role.\",\n      \"evidence\": \"Zebrafish mmachc mutant rescue with wild-type and cobalamin-binding-deficient MMACHC; chondrocyte morphological analysis\",\n      \"pmids\": [\"37167860\"],\n      \"confidence\": \"Medium\",\n      \"gaps\": [\"Molecular basis of the cobalamin-independent function completely undefined\", \"No mammalian validation\", \"Binding partners mediating this non-canonical function not identified\"]\n    },\n    {\n      \"year\": null,\n      \"claim\": \"Key unresolved questions include the atomic-resolution structure of the full MMACHC–MMADHC–MS–MSR complex, the kinetic mechanism of cobalamin handoff between complex members, the molecular basis of MMACHC's cobalamin-independent developmental roles, and whether therapeutic modulation of the thiol oxidase side reaction can ameliorate cblC disease.\",\n      \"evidence\": \"\",\n      \"pmids\": [],\n      \"confidence\": \"Low\",\n      \"gaps\": [\"No reconstituted in vitro transfer assay for the full four-protein complex\", \"Cobalamin-independent function mechanism entirely unknown\", \"No structural data for the intact multiprotein processing complex\"]\n    }\n  ],\n  \"mechanism_profile\": {\n    \"molecular_activity\": [\n      {\"term_id\": \"GO:0140096\", \"supporting_discovery_ids\": [1, 3, 11, 19]},\n      {\"term_id\": \"GO:0016491\", \"supporting_discovery_ids\": [2, 3, 14, 19]},\n      {\"term_id\": \"GO:0016787\", \"supporting_discovery_ids\": [1, 11]}\n    ],\n    \"localization\": [\n      {\"term_id\": \"GO:0005829\", \"supporting_discovery_ids\": [6, 12]}\n    ],\n    \"pathway\": [\n      {\"term_id\": \"GO:R-HSA-1430728\", \"supporting_discovery_ids\": [0, 1, 2, 12]},\n      {\"term_id\": \"GO:R-HSA-1643685\", \"supporting_discovery_ids\": [0, 11, 15]}\n    ],\n    \"complexes\": [\n      \"MMACHC-MMADHC-MS-MSR cobalamin processing complex\"\n    ],\n    \"partners\": [\n      \"MMADHC\",\n      \"MTR\",\n      \"MTRR\",\n      \"HCFC1\"\n    ],\n    \"other_free_text\": []\n  }\n}\n```"}